1. Бокерия Л.А., Затевахин И.И., Кириенко А.И. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений (ВТЭО)//Флебология. 2015. Т. 2, N 4. С. 2.

2. Perrin M., Eklof B., Maleti O. The vein glossary//J Vasc Surg Venous Lymphat Disord. 2018. Т. 6, N 5. С. 11 - 217.

3. Engelmann B., Massberg S. Thrombosis as an intravascular effector of innate immunity.//Nat. Rev. Immunol. Nature Publishing Group, 2013. Т. 13, N 1. С. 34 - 45.

4. Diaz J.A. и др. Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application.//J. Thromb. Haemost. Am Heart Assoc, 2019. Т. 17, N 4. С. 699 - 707.

5. и др. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.//J. Exp. Med. The Rockefeller University Press, 2012. Т. 209, N 4. С. 819 - 835.

6. Kumar N.G. и др. Fibrinolytic activity of endothelial cells from different venous beds.//J. Surg. Res. Elsevier, 2015. Т. 194, N 1. С. 297 - 303.

7. Gupta N., Zhao Y.-Y., Evans C.E. The stimulation of thrombosis by hypoxia.//Thromb. Res. Elsevier, 2019. Т. 181. С. 77 - 83.

8. Xu J. и др. Extracellular histones are major mediators of death in sepsis.//Nat. Med. Nature Publishing Group, 2009. Т. 15, N 11. С. 1318 - 1321.

9. Wakefield T.W., Myers D.D., Henke P.K. Role of selectins and fibrinolysis in VTE.//Thromb. Res. Elsevier, 2009. Т. 123 Suppl. С. S35 - 40.

10. Laurance S. и др. Gas6 Promotes Inflammatory (CCR2hiCX3CR1lo) Monocyte Recruitment in Venous Thrombosis.//Arterioscler. Thromb. Vasc. Biol. American Society of Hematology Washington, DC, 2017. Т. 37, N 7. С. 1315-1322.

11. Swystun L.L., Liaw P.C. The role of leukocytes in thrombosis.//Blood. American Society of Hematology Washington, DC, 2016. Т. 128, N 6. С. 753 - 762.

12. Barranco-Medina S. и др. Histone H4 promotes prothrombin autoactivation.//J. Biol. Chem. ASBMB, 2013. Т. 288, N 50. С. 35749 - 35757.

13. Fuchs T.A. и др. Extracellular DNA traps promote thrombosis.//Proc. Natl. Acad. Sci. U. S. A. National Acad Sciences, 2010. Т. 107, N 36. С. 15880 - 15885.

14. Ammollo C.T. и др. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation.//J. Thromb. Haemost. Wiley Online Library, 2011. Т. 9, N 9. С. 1795 - 1803.

15. Ward C.M. и др. Binding of the von Willebrand factor A1 domain to histone.//Thromb. Res. Elsevier, 1997. Т. 86, N 6. С. 469 - 477.

16. Semeraro F. и др. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4.//Blood. American Society of Hematology Washington, DC, 2011. Т. 118, N 7. С. 1952 - 1961.

17. Okano M. и др. In Vivo Imaging of Venous Thrombus and Pulmonary Embolism Using Novel Murine Venous Thromboembolism Model.//JACC. Basic to Transl. Sci. American College of Cardiology Foundation Washington DC, 2020. Т. 5, N 4. С. 344-356.

18. Cooley B.C. In vivo fluorescence imaging of large-vessel thrombosis in mice//Arterioscler. Thromb. Vasc. Biol. Am Heart Assoc, 2011. Т. 31, N 6. С. 1351 - 1356.

19. Shaya S.A. и др. Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.//J. Thromb. Haemost. Wiley Online Library, 2016. Т. 14, N 1. С. 143 - 152.

20. Shaya S.A. и др. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi.//Thromb. Haemost. Georg Thieme Verlag KG, 2019. Т. 119, N 6. С. 992 - 999.

21. Deroo S., Deatrick K.B., Henke P.K. The vessel wall: A forgotten player in post thrombotic syndrome.//Thromb. Haemost. Schattauer GmbH, 2010. Т. 104, N 4. С. 681 - 692.

22. Modarai B. и др. The role of neovascularisation in the resolution of venous thrombus.//Thromb. Haemost. Schattauer GmbH, 2005. Т. 93, N 5. С. 801 - 809.

23. Fineschi V. и др. Histological age determination of venous thrombosis: a neglected forensic task in fatal pulmonary thrombo-embolism.//Forensic Sci. Int. Elsevier, 2009. Т. 186, N 1-3. С. 22 - 28.

24. Lee Y.-U. и др. Histological and biomechanical changes in a mouse model of venous thrombus remodeling.//Biorheology. IOS Press, 2015. Т. 52, N 3. С. 235 - 245.

25. Comerota A.J. и др. A histological and functional description of the tissue causing chronic postthrombotic venous obstruction.//Thromb. Res. Elsevier, 2015. Т. 135, N 5. С. 882 - 887.

26. Aguilera C.M. и др. Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein.//Cardiovasc. Res. Elsevier Science, 2003. Т. 58, N 3. С. 679 - 688.

27. Nicklas J.M., Gordon A.E., Henke P.K. Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms.//Int. J. Mol. Sci. Multidisciplinary Digital Publishing Institute, 2020. Т. 21, N 6. С. 2080.

28. Adelman B. и др. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions.//Blood. 1985. Т. 65, N 1. С. 32 - 40.

29. Singh I. и др. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells.//Circulation. Am Heart Assoc, 2003. Т. 107, N 6. С. 869 - 875.

30. Suzuki Y. и др. Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells.//Blood. American Society of Hematology Washington, DC, 2011. Т. 118, N 11. С. 3182 - 3185.

31. Baldwin J.F. и др. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.//J. Vasc. Surg. Elsevier, 2012. Т. 56, N 4. С. 1089 - 1097.

32. Weitz J.I., Leslie B., Hirsh J. 2-Antiplasmin supplementation inhibits tissue plasminogen activator- induced fibrinogenolysis and bleeding with little effect on thrombolysis//J. Clin. Invest. Am Soc Clin Investig, 1993. Т. 91, N 4. С. 1343 - 1350.

33. Urano T., Castellino F.J., Suzuki Y. Regulation of plasminogen activation on cell surfaces and fibrin.//J. Thromb. Haemost. Wiley Online Library, 2018. Т. 16, N 8. С. 1487 - 1497.

34. Fields G.B. Interstitial collagen catabolism.//J. Biol. Chem. ASBMB, 2013. Т. 288, N 13. С. 8785 - 8793.

35. Mosevoll K.A. и др. Altered plasma levels of cytokines, soluble adhesion molecules and matrix metalloproteases in venous thrombosis.//Thromb. Res. Elsevier, 2015. Т. 136, N 1. С. 30 - 39.

36. Nguyen K.P. и др. Matrix Metalloproteinase 9 (MMP-9) Regulates Vein Wall Biomechanics in Murine Thrombus Resolution.//PLoS One. Public Library of Science San Francisco, CA USA, 2015. Т. 10, N 9. С. e0139145.

37. Nosaka M. и др. Time-dependent appearance of intrathrombus neutrophils and macrophages in a stasis-induced deep vein thrombosis model and its application to thrombus age determination.//Int. J. Legal Med. Springer, 2009. Т. 123, N 3. С. 235 - 240.

38. Kirsch R. и др. Fibrinogen is degraded and internalized during incubation with neutrophils, and fibrinogen products localize to electron lucent vesicles.//Biochem. J. Portland Press Ltd., 2002. Т. 364, N Pt 2. С. 403 - 412.

39. McGuinness C.L. и др. Recruitment of labelled monocytes by experimental venous thrombi.//Thromb. Haemost. Schattauer GmbH, 2001. Т. 85, N 6. С. 1018 - 1024.

40. Nathan C., Ding A. Nonresolving inflammation.//Cell. Elsevier, 2010. Т. 140, N 6. С. 871 - 882.

41. Chang C.-F. и др. Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage.//J. Clin. Invest. Am Soc Clin Investig, 2018. Т. 128, N 2. С. 607 - 624.

42. Dewyer N.A. и др. Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury.//Thromb. Haemost. Schattauer GmbH, 2015. Т. 114, N 5. С. 1028 - 1037.

43. Fleetwood A.J. и др. Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion.//J. Immunol. Am Assoc Immnol, 2014. Т. 192, N 8. С. 3540 - 3547.

44. Meznarich J. и др. Urokinase Plasminogen Activator Induces Pro-Fibrotic/M2 Phenotype in Murine Cardiac Macrophages//PLoS One/под ред. Frangogiannis N. Public Library of Science San Francisco, USA, 2013. Т. 8, N 3. С. e57837.

45. Sheng J. и др. M2 macrophage-mediated interleukin-4 signalling induces myofibroblast phenotype during the progression of benign prostatic hyperplasia.//Cell Death Dis. Nature Publishing Group, 2018. Т. 9, N 7. С. 755.

46. Lin F., Wang N., Zhang T. The role of endothelial-mesenchymal transition in development and pathological process.//IUBMB Life. Wiley Online Library, 2012. Т. 64, N 9. С. 717 - 723.

47. Piera-Velazquez S., Jimenez S.A. Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.//Physiol. Rev. American Physiological Society Bethesda, MD, 2019. Т. 99, N 2. С. 1281 - 1324.

48. Privratsky J.R., Newman D.K., Newman P.J. PECAM-1: conflicts of interest in inflammation.//Life Sci. Elsevier, 2010. Т. 87, N 3 - 4. С. 69 - 82.

49. Lertkiatmongkol P. и др. Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31).//Curr. Opin. Hematol. NIH Public Access, 2016. Т. 23, N 3. С. 253 - 259.

50. Li W.-D., Li X.-Q. Endothelial progenitor cells accelerate the resolution of deep vein thrombosis.//Vascul. Pharmacol. Elsevier, 2016. Т. 83. С. 10 - 16.

51. Podor T.J. и др. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.//J. Biol. Chem. ASBMB, 2002. Т. 277, N 9. С. 7529 - 7539.

52. Diaz J.A. и др. P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.//Arterioscler. Thromb. Vasc. Biol. Am Heart Assoc, 2015. Т. 35, N 4. С. 829 - 837.

53. Heit J.A., Spencer F.A., White R.H. The epidemiology of venous thromboembolism.//J. Thromb. Thrombolysis. Springer, 2016. Т. 41, N 1. С. 3 - 14.

54. Heit J.A. Epidemiology of venous thromboembolism//Nat. Rev. Cardiol. Nature Publishing Group, 2015. Т. 12, N 8. С. 464 - 474.

55. Spencer F.A. и др. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism.//J. Gen. Intern. Med. Wiley Online Library, 2006. Т. 21, N 7. С. 722 - 727.

56. Silverstein M.D. и др. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.//Arch. Intern. Med. American Medical Association, 1998. Т. 158, N 6. С. 585 - 593.

57. Naess I.A. и др. Incidence and mortality of venous thrombosis: a population-based study.//J. Thromb. Haemost. Wiley Online Library, 2007. Т. 5, N 4. С. 692 - 699.

58. Roach R.E.J. и др. Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment: reply.//J. Thromb. Haemost. Wiley Online Library, 2015. Т. 13, N 5. С. 886 - 887.

59. Kane E. V и др. A population-based study of venous thrombosis in pregnancy in Scotland 1980-2005.//Eur. J. Obstet. Gynecol. Reprod. Biol. Elsevier, 2013. Т. 169, N 2. С. 223 - 229.

60. Heit J.A. и др. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.//Ann. Intern. Med. American College of Physicians, 2005. Т. 143, N 10. С. 697 - 706.

61. White R.H., Zhou H., Romano P.S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California.//Ann. Intern. Med. American College of Physicians, 1998. Т. 128, N 9. С. 737 - 740.

62. Zakai N.A., McClure L.A., Judd S.E. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts//Circulation. Am Heart Assoc, 2014. Т. 129, N 14. С. 1502 - 1509.

63. Cheuk B.L.Y., Cheung G.C.Y., Cheng S.W.K. Epidemiology of venous thromboembolism in a Chinese population.//Br. J. Surg. Oxford University Press, 2004. Т. 91, N 4. С. 424 - 428.

64. Hooper W.C. и др. Venous thromboembolism hospitalizations among American Indians and Alaska Natives.//Thromb. Res. Elsevier, 2002. Т. 108, N 5 - 6. С. 273 - 278.

65. Khan F. и др. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.//BMJ. British Medical Journal Publishing Group, 2019. Т. 366. С. l4363.

66. Schulman S. и др. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.//J. Thromb. Haemost. Wiley Online Library, 2006. Т. 4, N 4. С. 734 - 742.

67. van Dongen C.J.J. и др. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.//Arch. Intern. Med. American Medical Association, 2003. Т. 163, N 11. С. 1285 - 1293.

68. Franchini M., Mannucci P.M. ABO blood group and thrombotic vascular disease.//Thromb. Haemost. Schattauer GmbH, 2014. Т. 112, N 6. С. 1103 - 1109.

69. Bank I. и др. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.//Arch. Intern. Med. American Medical Association, 2004. Т. 164, N 17. С. 1932 - 1937.

70. Olaf M., Cooney R. Deep Venous Thrombosis.//Emerg. Med. Clin. North Am. Elsevier, 2017. Т. 35, N 4. С. 743 - 770.

71. Томченко А.И. и др. Группы крови AB0 и тромбоз глубоких вен нижних конечностей у пациентов пожилого и старческого возраста.//Флебология. 2021. Т. 15, N 1.

72. Чечулова А.В. и др. Оценка ген-генных взаимодействий ряда факторов плазменного звена гемостаза у пациентов с ранним дебютом венозных тромбоэмболических осложнений.//Флебология. 2021. Т. 15, N 1.

73. Гаврилов Е.К. и др. Возможное значение наследственных тромбофилий в возникновении и осложненном течении идиопатических острых венозных тромбозов нижних конечностей//Флебология. Общество с ограниченной ответственностью Издательство Медиа Сфера, 2020. Т. 14, N 2. С. 83 - 88.

74. van Stralen K.J. и др. Mechanisms of the factor V Leiden paradox.//Arterioscler. Thromb. Vasc. Biol. Am Heart Assoc, 2008. Т. 28, N 10. С. 1872 - 1877.

75. Meissner M.H. Epidemiology and risk factors of acute venous thrombosis//Handbook of Venous and Lymphatic Disorders. CRC Press, 2017. С. 107 - 119.

76. van Hylckama Vlieg A., Middeldorp S. Hormone therapies and venous thromboembolism: where are we now?//J. Thromb. Haemost. Wiley Online Library, 2011. Т. 9, N 2. С. 257 - 266.

77. de Bastos M. и др. Combined oral contraceptives: venous thrombosis.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2014. N 3. С. CD010813.

78. Roderick P. Epidemiology of Venous Thromboembolism//Clin. Risk. Elsevier, 1997. Т. 3, N 3. С. 69 - 74.

79. Ay C. и др. Prediction of venous thromboembolism in cancer patients.//Blood. American Society of Hematology Washington, DC, 2010. Т. 116, N 24. С. 5377 - 5382.

80. Sciascia S. и др. Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay.//Clin. Mol. Allergy. Springer, 2016. Т. 14, N 1. С. 6.

81. Gris J.-C. и др. Thrombosis and paroxysmal nocturnal haemoglobinuria//Thromb. Updat. Elsevier, 2021. Т. 5. С. 100074.

82. Mazzolai L. и др. Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular fu//Eur. J. Prev. Cardiol. 2022. Т. 29, N 8. С. 1248 - 1263.

83. Kearon C. и др. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH.//J. Thromb. Haemost. 2016. Т. 14, N 7. С. 1480 - 1483.

84. Konstantinides S. V., Meyer G., Gali N. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)//Eur. Respir. J. European Respiratory Society, 2019. Т. 54, N 3.

85. Kakkos S., Gohel M., Baekgaard N. Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis//Eur. J. Vasc. Endovasc. Surg. Eur J Vasc Endovasc Surg, 2021. Т. 61, N 1. С. 9 - 82.

86. Stevens S.M. и др. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.//Chest. Elsevier, 2021. Т. 160, N 6. С. e545 - e608.

87. Prins M.H. и др. Risk of recurrent venous thromboembolism according to baseline risk factor profiles.//Blood Adv. American Society of Hematology Washington, DC, 2018. Т. 2, N 7. С. 788 - 796.

88. Key N.S. и др. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.//J. Clin. Oncol. American Society of Clinical Oncology, 2020. Т. 38, N 5. С. 496 - 520.

89. Iorio A. и др. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.//Arch. Intern. Med. American Medical Association, 2010. Т. 170, N 19. С. 1710 - 1716.

90. Alhabouni S. и др. PP88. Lower Extremity Occlusive vs Non-occlusive DVT and the Risk of Pulmonary Embolism//J. Vasc. Surg. Elsevier, 2009. Т. 49, N 5. С. S40.

91. Pacouret G. Free-Floating Thrombus and Embolic Risk in Patients With Angiographically Confirmed Proximal Deep Venous Thrombosis. A Prospective Study//Arch. Intern. Med. American Medical Association, 1997. Т. 157, N 3. С. 305.

92. Ortel T.L. и др. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.//Blood Adv. American Society of Hematology Washington, DC, 2020. Т. 4, N 19. С. 4693 - 4738.

93. Robert-Ebadi H., Righini M. Should we diagnose and treat distal deep vein thrombosis?//Hematol. Am. Soc. Hematol. Educ. Progr. American Society of Hematology Washington, DC, 2017. Т. 2017, N 1. С. 231 - 236.

94. Крутько В.С., Потейко П.И., Ходош Э.М. Наружные симптомы у больных с тромбоэмболией легочной артерии//Медицина неотложных состояний. ФЛП "Заславский Александр Юрьевич", 2013. N 2 (49).

95. Небылицин Ю.С., Сушков С.А. Диагностика тромбоза глубоких вен нижних конечностей//Новости хирургии. Учреждение образования "Витебский государственный ордена Дружбы народов..., 2007. Т. 15, N 3.

96. Бойко В.В., Криворотько И.В. Стратегия хирургического лечения местнораспространенных опухолей малого таза с применением эвисцераций. Сообщение 3. Рак прямой кишки, матки, яичников, предстательной железы, тератоидные опухоли малого таза//Международный медицинский журнал. нститут проблем кр об олог кр омедицини НАН Укра ни, 2008.

97. Greer I.A. CLINICAL PRACTICE. Pregnancy Complicated by Venous Thrombosis.//N. Engl. J. Med. Mass Medical Soc, 2015. Т. 373, N 6. С. 540 - 547.

98. Chan W.-S., Spencer F.A., Ginsberg J.S. Anatomic distribution of deep vein thrombosis in pregnancy.//CMAJ. Can Med Assoc, 2010. Т. 182, N 7. С. 657 - 660.

99. Wells P.S. Integrated strategies for the diagnosis of venous thromboembolism.//J. Thromb. Haemost. Wiley Online Library, 2007. Т. 5 Suppl 1. С. 41 - 50.

100. Wells P.S. и др. Does this patient have deep vein thrombosis?//JAMA. American Medical Association, 2006. Т. 295, N 2. С. 199 - 207.

101. , Bounameaux H., Levi M. Scores and Algorithms in Haemostasis and Thrombosis. 2014.

102. Geersing G.J. и др. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis.//BMJ. British Medical Journal Publishing Group, 2014. Т. 348. С. g1340.

103. Wells P.S., Anderson D.R., Rodger M. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer//Thromb. Haemost. Schattauer GmbH, 2000. Т. 83, N 03. С. 416 - 420.

104. Shen J.-H. и др. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis.//J. Thromb. Thrombolysis. Springer, 2016. Т. 41, N 3. С. 482 - 492.

105. Le Gal G. и др. Prediction of pulmonary embolism in the emergency department: the revised Geneva score.//Ann. Intern. Med. American College of Physicians, 2006. Т. 144, N 3. С. 165 - 171.

106. Tritschler T. и др. Venous Thromboembolism: Advances in Diagnosis and Treatment.//JAMA. American Medical Association, 2018. Т. 320, N 15. С. 1583 - 1594.

107. Cuker A. и др. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia//Blood Adv. American Society of Hematology Washington, DC, 2018. Т. 2, N 22. С. 3360 - 3392.

108. Bernardi E., Camporese G. Diagnosis of deep-vein thrombosis.//Thromb. Res. Elsevier, 2018. Т. 163. С. 201 - 206.

109. Michiels J.J. и др. Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward.//Int. Angiol. 2014. Т. 33, N 1. С. 1 - 19.

110. Streiff M.B. и др. Guidance for the treatment of deep vein thrombosis and pulmonary embolism.//J. Thromb. Thrombolysis. Springer, 2016. Т. 41, N 1. С. 32 - 67.

111. Ye F. и др. Venothromboembolic signs and medical eponyms: Part II.//Thromb. Res. Elsevier, 2019. Т. 182. С. 205 - 213.

112. Goodacre S., Sutton A.J., Sampson F.C. Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis.//Ann. Intern. Med. American College of Physicians, 2005. Т. 143, N 2. С. 129 - 139.

113. Michiels J.J. и др. A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?//Int. Angiol. Edizioni Minerva Medica, 2005. Т. 24, N 1. С. 27-39.

114. Sartori M. и др. The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis.//J. Thromb. Haemost. Wiley Online Library, 2012. Т. 10, N 11. С. 2264 - 2269.

115. Al-Khafaji R.A., Schierbeck L. Deep Venous Thrombosis in a Patient with a Moderate Pretest Probability and a Negative D-Dimer Test: A Review of the Diagnostic Algorithms//J. Blood Med. Dove Press, 2020. Т. Volume 11. С. 173 - 184.

116. Huisman M. V, Klok F.A. Diagnostic management of acute deep vein thrombosis and pulmonary embolism.//J. Thromb. Haemost. Wiley Online Library, 2013. Т. 11, N 3. С. 412 - 422.

117. Le Gal G., Righini M. Controversies in the diagnosis of venous thromboembolism.//J. Thromb. Haemost. Wiley Online Library, 2015. Т. 13 Suppl 1. С. S259-65.

118. Stone J. и др. Deep vein thrombosis: pathogenesis, diagnosis, and medical management.//Cardiovasc. Diagn. Ther. AME Publications, 2017. Т. 7, N Suppl 3. С. S276 - S284.

119. Hargett C.W., Tapson V.F. Clinical probability and D-dimer testing: how should we use them in clinical practice?//Semin. Respir. Crit. Care Med. (C) Thieme Medical Publishers, 2008. Т. 29, N 1. С. 15 - 24.

120. Hirsh J. и др. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).//Chest. 2008. Т. 133, N 6 Suppl. С. 141S - 159S.

121. Hong J. и др. Updated recommendations for the treatment of venous thromboembolism.//Blood Res. Korean Society of Hematology; Korean Society of Blood and Marrow..., 2021. Т. 56, N 1. С. 6 - 16.

122. Garcia D.A. и др. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.//Chest. Elsevier, 2012. Т. 141, N 2 Suppl. С. e24S - e43S.

123. DeWald T.A., Washam J.B., Becker R.C. Anticoagulants: Pharmacokinetics, Mechanisms of Action, and Indications.//Neurosurg. Clin. N. Am. Elsevier, 2018. Т. 29, N 4. С. 503 - 515.

124. Guyatt G.H. и др. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.//Chest. 2012. Т. 141, N 2 Suppl. С. 7S - 47S.

125. Chen A., Stecker E., A Warden B. Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges.//J. Am. Heart Assoc. Am Heart Assoc, 2020. Т. 9, N 13. С. e017559.

126. Guyatt G.H., Akl E.A., Crowther M. Executive summary: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines//Chest. American College of Chest Physicians, 2012. Т. 141, N 2 Suppl. С. 7S.

127. Wu T. и др. The effect of anti Xa monitoring on the safety and efficacy of low molecular weight heparin anticoagulation therapy: A systematic review and meta analysis//J. Clin. Pharm. Ther. Wiley Online Library, 2020. Т. 45, N 4. С. 602 - 608.

128. Hutt Centeno E., Militello M., Gomes M.P. Anti-Xa assays: What is their role today in antithrombotic therapy?//Cleve. Clin. J. Med. 2019. Т. 86, N 6. С. 417 - 425.

129. Kufel W.D. и др. Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?//Hosp. Pharm. SAGE Publications Sage CA: Los Angeles, CA, 2017. Т. 52, N 3. С. 214 - 220.

130. Smythe M.A. и др. Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.//J. Thromb. Thrombolysis. Springer, 2016. Т. 41, N 1. С. 165 - 186.

131. Verhoeff K. и др. Relationship between anti-Xa level achieved with prophylactic low-molecular weight heparin and venous thromboembolism in trauma patients: A systematic review and meta-analysis.//J. Trauma Acute Care Surg. 2022. Т. 93, N 2. С. e61 - e70.

132. Witt D.M. и др. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.//Blood Adv. American Society of Hematology Washington, DC, 2018. Т. 2, N 22. С. 3257 - 3291.

133. Zuker-Herman R. и др. Comparison between two-point and three-point compression ultrasound for the diagnosis of deep vein thrombosis.//J. Thromb. Thrombolysis. Springer, 2018. Т. 45, N 1. С. 99 - 105.

134. Needleman L. и др. Ultrasound for Lower Extremity Deep Venous Thrombosis: Multidisciplinary Recommendations From the Society of Radiologists in Ultrasound Consensus Conference.//Circulation. Am Heart Assoc, 2018. Т. 137, N 14. С. 1505 - 1515.

135. Lim W., Le Gal G., Bates S.M. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism//Blood Adv. American Society of Hematology Washington, DC, 2018. Т. 2, N 22. С. 3226 - 3256.

136. Maufus M. и др. Diagnosis of deep vein thrombosis recurrence: Ultrasound criteria.//Thromb. Res. Elsevier, 2018. Т. 161. С. 78 - 83.

137. Goodacre S. и др. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis.//BMC Med. Imaging. Springer, 2005. Т. 5, N 1. С. 6.

138. Righini M. и др. Clinical relevance of distal deep vein thrombosis. Review of literature data.//Thromb. Haemost. Schattauer GmbH, 2006. Т. 95, N 1. С. 56 - 64.

139. Kraaijpoel N. и др. Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis.//PLoS One. Public Library of Science San Francisco, CA USA, 2020. Т. 15, N 2. С. e0228788.

140. Bernardi E. и др. Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial.//JAMA. American Medical Association, 2008. Т. 300, N 14. С. 1653 - 1659.

141. Gibson N.S. и др. Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study.//J. Thromb. Haemost. Wiley Online Library, 2009. Т. 7, N 12. С. 2035 - 2041.

142. Hull R.D. и др. The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.//Circulation. Am Heart Assoc, 1983. Т. 67, N 4. С. 901 - 906.

143. Tzoran I. и др. Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs.//J. Thromb. Haemost. Wiley Online Library, 2012. Т. 10, N 4. С. 564 - 571.

144. Stein P.D. и др. Silent pulmonary embolism in patients with deep venous thrombosis: a systematic review.//Am. J. Med. Elsevier, 2010. Т. 123, N 5. С. 426 - 431.

145. Girard P. и др. Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy.//Am. J. Respir. Crit. Care Med. American Thoracic Society New York, NY, 2001. Т. 164, N 6. С. 1033 - 1037.

146. Garc a-Fuster M.J. и др. Should we look for silent pulmonary embolism in patients with deep venous thrombosis?//BMC Cardiovasc. Disord. Springer, 2014. Т. 14, N 1. С. 178.

147. Hughes M.J., Stein P.D., Matta F. Silent pulmonary embolism in patients with distal deep venous thrombosis: systematic review.//Thromb. Res. Elsevier, 2014. Т. 134, N 6. С. 1182 - 1185.

148. Kakkos S.K., Kirkilesis G.I., Tsolakis I.A. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2014. Т. 48, N 5. С. 565 - 575.

149. Barbar S. и др. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.//J. Thromb. Haemost. Wiley Online Library, 2010. Т. 8, N 11. С. 2450 - 2457.

150. Whitlock R.P., Sun J.C., Fremes S.E. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines//Chest. Elsevier, 2012. Т. 141, N 2. С. e44S - e88S.

151. Pandor A. и др. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review//BMJ Open. Schattauer GmbH, 2021. Т. 11, N 7. С. e045672.

152. Raskob G.E. и др. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.//Thromb. Haemost. Citeseer, 2016. Т. 115, N 6. С. 1240 - 1248.

153. Gibson C.M. и др. The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification.//TH open companion J. to Thromb. Haemost. Georg Thieme Verlag KG, 2017. Т. 1, N 1. С. e56 - e65.

154. Spyropoulos A.C. и др. Predictive and associative models to identify hospitalized medical patients at risk for VTE.//Chest. Elsevier, 2011. Т. 140, N 3. С. 706 - 714.

155. Pannucci C.J. и др. Individualized Venous Thromboembolism Risk Stratification Using the 2005 Caprini Score to Identify the Benefits and Harms of Chemoprophylaxis in Surgical Patients: A Meta-analysis.//Ann. Surg. LWW, 2017. Т. 265, N 6. С. 1094 - 1103.

156. Hanh B.M. и др. Determination of Risk Factors for Venous Thromboembolism by an Adapted Caprini Scoring System in Surgical Patients.//J. Pers. Med. Multidisciplinary Digital Publishing Institute, 2019. Т. 9, N 3. С. 36.

157. Cramer J.D. и др. Risk of Venous Thromboembolism Among Otolaryngology Patients vs General Surgery and Plastic Surgery Patients//JAMA Otolaryngol. Neck Surg. American Medical Association, 2017. Т. 144, N 1. С. 9 - 17.

158. Grant P.J. и др. Assessing the Caprini Score for Risk Assessment of Venous Thromboembolism in Hospitalized Medical Patients.//Am. J. Med. Elsevier, 2016. Т. 129, N 5. С. 528 - 535.

159. Лобастов К.В. и др. Шкала Caprini как инструмент для индивидуальной стратификации риска развития послеоперационных венозных тромбоэмболий в группе высокого риска//Хирургия. Журнал им. НИ Пирогова. Общество с ограниченной ответственностью Издательство Медиа Сфера, 2014. N 12. С. 16 - 23.

160. Pannucci C.J. и др. Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients.//Plast. Reconstr. Surg. NIH Public Access, 2011. Т. 128, N 5. С. 1093 - 1103.

161. Shuman A.G. и др. Stratifying the risk of venous thromboembolism in otolaryngology.//Otolaryngol. Head. Neck Surg. SAGE Publications Sage CA: Los Angeles, CA, 2012. Т. 146, N 5. С. 719 - 724.

162. Obi A.T., Pannucci C.J., Nackashi A. Validation of the Caprini venous thromboembolism risk assessment model in critically ill surgical patients//JAMA Surg. American Medical Association, 2015. Т. 150, N 10. С. 941 - 948.

163. Yarlagadda B.B. и др. Venous thromboembolism in otolaryngology surgical inpatients receiving chemoprophylaxis.//Head Neck. Wiley Online Library, 2014. Т. 36, N 8. С. 1087 - 1093.

164. Lobastov K. и др. Utilization of the Caprini score in conjunction with thrombodynamic testing reduces the number of unpredicted postoperative venous thromboembolism events in patients with colorectal cancer.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2020. Т. 8, N 1. С. 31 - 41.

165. Lobastov K. и др. Validation of the Caprini risk assessment model for venous thromboembolism in high-risk surgical patients in the background of standard prophylaxis.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2016. Т. 4, N 2. С. 153 - 160.

166. Paz Rios L.H. и др. Validation of a Patient-Completed Caprini Risk Assessment Tool for Spanish, Arabic, and Polish Speakers.//Clin. Appl. Thromb. Hemost. SAGE Publications Sage CA: Los Angeles, CA, 2018. Т. 24, N 3. С. 502 - 512.

167. Fuentes H.E. и др. Validation of a Patient-Completed Caprini Risk Score for Venous Thromboembolism Risk Assessment.//TH open companion J. to Thromb. Haemost. Georg Thieme Verlag KG, 2017. Т. 1, N 2. С. e106 - e112.

168. Chen X. и др. Clinical Validation of the Chinese Version of Patient Completed Caprini Risk Assessment Form//Clin. Appl. Thromb. SAGE Publications Sage CA: Los Angeles, CA, 2020. Т. 26. С. 107602962094503.

169. Лобастов К.В., Саутина Е.В. К.А.В. Конкурентная валидация русскоязычной версии пациент-ориентированного опросника на основе шкалы Каприни у хирургических пациентов//Флебология. 2022. Т. 1, N 16. С. 6 - 15.

170. Khorana A.A. и др. Development and validation of a predictive model for chemotherapy-associated thrombosis.//Blood. American Society of Hematology Washington, DC, 2008. Т. 111, N 10. С. 4902 - 4907.

171. Verso M. и др. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score.//Intern. Emerg. Med. Springer Nature BV, 2012. Т. 7, N 3. С. 291 - 292.

172. Pelzer U. и др. Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?//DMW - Dtsch. Medizinische Wochenschrift. 2013. Т. 138, N 41. С. 2084 - 2088.

173. van Es N. и др. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study.//Haematologica. Ferrata Storti Foundation, 2017. Т. 102, N 9. С. 1494 - 1501.

174. van Es N. и др. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis.//J. Thromb. Haemost. Wiley Online Library, 2020. Т. 18, N 8. С. 1940 - 1951.

175. Eichinger S. и др. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.//Circulation. Am Heart Assoc, 2010. Т. 121, N 14. С. 1630 - 1636.

176. Ensor J. и др. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.//BMJ Open. British Medical Journal Publishing Group, 2016. Т. 6, N 5. С. e011190.

177. Tosetto A. и др. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).//J. Thromb. Haemost. Wiley Online Library, 2012. Т. 10, N 6. С. 1019 - 1025.

178. van Hylckama Vlieg A., Baglin T.P. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study: reply.//J. Thromb. Haemost. Wiley Online Library, 2015. Т. 13, N 12. С. 2286 - 2287.

179. Rodger M.A. и др. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.//CMAJ. Can Med Assoc, 2008. Т. 179, N 5. С. 417 - 426.

180. Rodger M.A. и др. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.//BMJ. British Medical Journal Publishing Group, 2017. Т. 356. С. j1065.

181. Pisters R. и др. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.//Chest. Elsevier, 2010. Т. 138, N 5. С. 1093 - 1100.

182. Brown J.D. и др. Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.//J. Am. Heart Assoc. Am Heart Assoc, 2018. Т. 7, N 6. С. e007901.

183. Kooiman J. и др. The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment.//PLoS One. Public Library of Science San Francisco, CA USA, 2015. Т. 10, N 4. С. e0122520.

184. Zhu W., He W., Guo L. The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis//Clinical Cardiology. Wiley Online Library, 2015. Т. 38, N 9. С. 555-561.

185. Santise G. и др. The HAS-BLED Score is Associated With Major Bleeding in Patients After Cardiac Surgery.//J. Cardiothorac. Vasc. Anesth. Elsevier, 2019. Т. 33, N 6. С. 1601 - 1606.

186. Castini D. и др. Utility of the HAS-BLED score for risk stratification of patients with acute coronary syndrome.//Heart Vessels. Springer, 2019. Т. 34, N 10. С. 1621 - 1630.

187. Kresoja K.-P. и др. Prediction and prognostic importance of in-hospital major bleeding in a real-world cohort of patients with pulmonary embolism.//Int. J. Cardiol. Elsevier, 2019. Т. 290. С. 144 - 149.

188. Klok F.A. и др. Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment.//Eur. Respir. J. Eur Respiratory Soc, 2016. Т. 48, N 5. С. 1369 - 1376.

189. Klok F.A. и др. Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.//Br. J. Haematol. Wiley Online Library, 2018. Т. 183, N 3. С. 457 - 465.

190. и др. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.//Thromb. Haemost. Schattauer GmbH, 2008. Т. 100, N 1. С. 26 - 31.

191. Palareti G. и др. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.//J. Thromb. Haemost. Wiley Online Library, 2018. Т. 16, N 10. С. 1994 - 2002.

192. Klarin D. и др. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease.//Nat. Genet. Nature Publishing Group, 2019. Т. 51, N 11. С. 1574 - 1579.

193. и др. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.//Blood. American Society of Hematology, 2019. Т. 134, N 19. С. 1645 - 1657.

194. Stevens S.M. и др. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.//J. Thromb. Thrombolysis. Springer, 2016. Т. 41, N 1. С. 154 - 164.

195. Hirmerova J., Seidlerova J., Subrt I. The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox.//QJM. Oxford University Press, 2014. Т. 107, N 9. С. 715 - 720.

196. Poort S.R. и др. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.//Blood. 1996. Т. 88, N 10. С. 3698 - 3703.

197. Emmerich J. и др. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.//Thromb. Haemost. Schattauer GmbH, 2001. Т. 86, N 3. С. 809 - 816.

198. Wolberg A.S. Fibrinogen and factor XIII: Newly recognized roles in venous thrombus formation and composition//Current Opinion in Hematology. NIH Public Access, 2018. Т. 25, N 5. С. 358 - 364.

199. Ahmad A. и др. Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.//J. Thromb. Thrombolysis. Springer, 2019. Т. 47, N 2. С. 216 - 226.

200. Решетняк Т.М. Рекомендации по лечению антифосфолипидного синдрома//Москва. 2013.

201. Tektonidou M.G. и др. EULAR recommendations for the management of antiphospholipid syndrome in adults.//Ann. Rheum. Dis. BMJ Publishing Group Ltd, 2019. Т. 78, N 10. С. 1296 - 1304.

202. Кулагин А.Д., Лисуков И.А., Птушкин В.В. Национальные клинические рекомендации по диагностике и лечению пароксизмальной ночной гемоглобинурии//Онкогематология. Общество с ограниченной ответственностью "Издательский дом "АБВ-пресс", 2014. N 2.

203. NICE G. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE London, 2015.

204. Baglin T., Luddington R., Brown K. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study//Lancet (London, England). Lancet, 2003. Т. 362, N 9383. С. 523 - 526.

205. Weingarz L. и др. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry.//Br. J. Haematol. Wiley Online Library, 2013. Т. 163, N 5. С. 655 - 665.

206. Chechulova A. V и др. Genetic Markers of Hereditary Thrombophilia and the Clinical Course for Venous Thromboembolism in Young Patients from the North-West of Russian Federation//Flebologiia. 2020. Т. 14, N 1. С. 6.

207. Coppens M., Reijnders J.H., Middeldorp S. Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis//J. Thromb. Haemost. Wiley Online Library, 2008. Т. 6, N 9. С. 1474 - 1477.

208. Connors J.M. Thrombophilia testing and venous thrombosis//N. Engl. J. Med. Mass Medical Soc, 2017. Т. 377, N 12. С. 1177 - 1187.

209. Garcia-Horton A. и др. Impact of thrombophilia screening on venous thromboembolism management practices.//Thromb. Res. Elsevier, 2017. Т. 149. С. 76 - 80.

210. Moll S. Thrombophilia: clinical-practical aspects.//J. Thromb. Thrombolysis. Springer, 2015. Т. 39, N 3. С. 367 - 378.

211. Ortel T.L. и др. Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta analysis//J. Thromb. Haemost. Wiley Online Library, 2020. Т. 18, N 9. С. 2274 - 2286.

212. Сомонова О.В., Антух Э.А., Елизарова А.Л. Практические рекомендации по профилактике и лечению тромбоэмболических осложнений у онкологических больных//Злокачественные опухоли. Благотворительный фонд содействия профилактике, диагностике и лечению..., 2017. Т. 7, N 3-S2. С. 553 - 558.

213. Zhou M. и др. Extensive screening for occult malignancy in unprovoked venous thromboembolism: A meta-analysis.//Thromb. Res. Elsevier, 2017. Т. 157. С. 147 - 153.

214. Jara-Palomares L. и др. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE.//Chest. Elsevier, 2017. Т. 151, N 3. С. 564 - 571.

215. Lyman G.H. и др. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.//Blood Adv. American Society of Hematology Washington, DC, 2021. Т. 5, N 4. С. 927 - 974.

216. Klein A. и др. Screening for occult cancer in idiopathic venous thromboembolism - Systemic review and meta-analysis.//Eur. J. Intern. Med. Elsevier, 2017. Т. 42. С. 74 - 80.

217. Kleinjan A. и др. Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism.//Neth. J. Med. 2012. Т. 70, N 7. С. 311 - 317.

218. Robertson L. и др. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE//Cochrane Database Syst. Rev. John Wiley & Sons, Ltd, 2021. Т. 2021, N 10.

219. Калинин Р.Е., Сучков И.А., Землянухин С.П. Идиопатический тромбоз глубоких вен: определение стратегии скрининга скрытого рака//Флебология. 2020. Т. 14, N 2.

220. Эрлих А.Д. и др. Тромбоэмболия легочных артерий у пациентов с онкологическими заболеваниями. Данные регистра СИРЕНА.//Флебология. 2021. Т. 15, N 3.

221. Ploton G. и др. A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis.//Medicine (Baltimore). Wolters Kluwer Health, 2020. Т. 99, N 6. С. e18996.

222. Heil J. и др. Deep Vein Thrombosis of the Upper Extremity.//Dtsch. Arztebl. Int. Deutscher Arzte-Verlag GmbH, 2017. Т. 114, N 14. С. 244 - 249.

223. Major K.M. и др. Internal jugular, subclavian, and axillary deep venous thrombosis and the risk of pulmonary embolism.//Vascular. SAGE Publications Sage UK: London, England, 2008. Т. 16, N 2. С. 73 - 79.

224. Mustafa S. и др. Upper extremity deep venous thrombosis.//Chest. Elsevier, 2003. Т. 123, N 6. С. 1953 - 1956.

225. Joffe H. V, Goldhaber S.Z. Upper-extremity deep vein thrombosis.//Circulation. Am Heart Assoc, 2002. Т. 106, N 14. С. 1874 - 1880.

226. Sajid M.S. и др. Upper limb deep vein thrombosis: a literature review to streamline the protocol for management.//Acta Haematol. Karger Publishers, 2007. Т. 118, N 1. С. 10 - 18.

227. Grant J.D. и др. Diagnosis and management of upper extremity deep-vein thrombosis in adults.//Thromb. Haemost. Schattauer GmbH, 2012. Т. 108, N 6. С. 1097 - 1108.

228. Flinterman L.E. и др. Current perspective of venous thrombosis in the upper extremity.//J. Thromb. Haemost. Wiley Online Library, 2008. Т. 6, N 8. С. 1262-1266.

229. Martinelli I. и др. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.//Circulation. Am Heart Assoc, 2004. Т. 110, N 5. С. 566-570.

230. Hendler M.F. и др. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.//Am. J. Hematol. Wiley Online Library, 2004. Т. 76, N 4. С. 330 - 337.

231. Prandoni P. и др. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications.//Arch. Intern. Med. American Medical Association, 1997. Т. 157, N 1. С. 57 - 62.

232. Di Nisio M. и др. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review.//J. Thromb. Haemost. Wiley Online Library, 2010. Т. 8, N 4. С. 684 - 692.

233. Douma R.A. и др. Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study.//Ann. Intern. Med. American College of Physicians, 2011. Т. 154, N 11. С. 709 - 718.

234. Wells P.S. и др. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer.//Ann. Intern. Med. American College of Physicians, 2001. Т. 135, N 2. С. 98 - 107.

235. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).//JAMA. 1990. Т. 263, N 20. С. 2753 - 2759.

236. Lucassen W. и др. Clinical decision rules for excluding pulmonary embolism: a meta-analysis.//Ann. Intern. Med. American College of Physicians, 2011. Т. 155, N 7. С. 448 - 460.

237. van Belle A. и др. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.//JAMA. 2006. Т. 295, N 2. С. 172 - 179.

238. Musset D. и др. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study.//Lancet (London, England). Elsevier, 2002. Т. 360, N 9349. С. 1914 - 1920.

239. Perrier A. и др. Non-invasive diagnosis of venous thromboembolism in outpatients.//Lancet (London, England). Elsevier, 1999. Т. 353, N 9148. С. 190 - 195.

240. Sostman H.D. и др. Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study.//Radiology. Radiological Society of North America, 2008. Т. 246, N 3. С. 941 - 946.

241. Righini M. и др. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial.//Lancet (London, England). Elsevier, 2008. Т. 371, N 9621. С. 1343 - 1352.

242. Anderson D.R. и др. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial.//JAMA. American Medical Association, 2007. Т. 298, N 23. С. 2743 - 2753.

243. Perrier A. и др. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study.//Am. J. Med. Elsevier, 2004. Т. 116, N 5. С. 291 - 299.

244. Di Nisio M. и др. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review.//J. Thromb. Haemost. Wiley Online Library, 2007. Т. 5, N 2. С. 296 - 304.

245. Stein P.D. и др. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.//Ann. Intern. Med. American College of Physicians, 2004. Т. 140, N 8. С. 589 - 602.

246. Ceriani E. и др. Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis//J. Thromb. Haemost. Wiley Online Library, 2010. Т. 8, N 5. С. 957 - 970.

247. Patel S., Kazerooni E.A., Cascade P.N. Pulmonary embolism: optimization of small pulmonary artery visualization at multi-detector row CT.//Radiology. Radiological Society of North America, 2003. Т. 227, N 2. С. 455 - 460.

248. Ghaye B. и др. Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis?//Radiology. Radiological Society of North America, 2001. Т. 219, N 3. С. 629 - 636.

249. Carrier M. и др. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies.//J. Thromb. Haemost. Wiley Online Library, 2010. Т. 8, N 8. С. 1716 - 1722.

250. Patel P. и др. Systematic review and meta-analysis of test accuracy for the diagnosis of suspected pulmonary embolism//Blood Adv. American Society of Hematology Washington, DC, 2020. Т. 4, N 18. С. 4296 - 4311.

251. Qanadli S.D. и др. Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients.//Radiology. Radiological Society of North America, 2000. Т. 217, N 2. С. 447 - 455.

252. Stein P.D. и др. Complications and validity of pulmonary angiography in acute pulmonary embolism.//Circulation. Am Heart Assoc, 1992. Т. 85, N 2. С. 462 - 468.

253. Engelberger R.P., Kucher N. Catheter-based reperfusion treatment of pulmonary embolism.//Circulation. Am Heart Assoc, 2011. Т. 124, N 19. С. 2139 - 2144.

254. Reid J.H. и др. Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT.//Eur. J. Nucl. Med. Mol. Imaging. Springer, 2009. Т. 36, N 3. С. 505 - 521.

255. Roy P.-M. и др. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism.//BMJ. British Medical Journal Publishing Group, 2005. Т. 331, N 7511. С. 259.

256. van Es J. и др. Accuracy of X-ray with perfusion scan in young patients with suspected pulmonary embolism.//Thromb. Res. Elsevier, 2015. Т. 136, N 2. С. 221 - 224.

257. Kucher N. и др. Novel management strategy for patients with suspected pulmonary embolism.//Eur. Heart J. Oxford University Press, 2003. Т. 24, N 4. С. 366 - 376.

258. Elliott C.G. и др. Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry.//Chest. Elsevier, 2000. Т. 118, N 1. С. 33 - 38.

259. Shopp J.D. и др. Findings From 12-lead Electrocardiography That Predict Circulatory Shock From Pulmonary Embolism: Systematic Review and Meta-analysis.//Acad. Emerg. Med. Wiley Online Library, 2015. Т. 22, N 10. С. 1127 - 1137.

260. Revel M.P. и др. Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the "IRM-EP" study.//J. Thromb. Haemost. Wiley Online Library, 2012. Т. 10, N 5. С. 743 - 750.

261. Stein P.D. и др. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III).//Ann. Intern. Med. American College of Physicians, 2010. Т. 152, N 7. С. 434-443, W142-3.

262. Trujillo-Santos J. и др. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs.//Am. J. Med. Elsevier, 2015. Т. 128, N 1. С. 90. e9 - 15.

263. Othieno R., Okpo E., Forster R. Home versus in-patient treatment for deep vein thrombosis.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2018. Т. 1, N 1. С. CD003076.

264. Lozano F. и др. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.//J. Vasc. Surg. Elsevier, 2014. Т. 59, N 5. С. 1362-7.e1.

265. Лобастов К.В., Воронцова А.В., Барганджия А.Б. Амбулаторное лечение тромбоза глубоких вен ривароксабаном: опыт работы в одном центре//Флебология. 2020. Т. 14, N 2. С. 99 - 106.

266. Barco S. и др. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.//Eur. Heart J. Oxford University Press, 2020. Т. 41, N 4. С. 509 - 518.

267. Broderick C., Watson L., Armon M.P. Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb.//Cochrane database Syst. Rev. Cochrane Database Syst Rev, 2021. Т. 1, N 1. С. CD002783.

268. Lu Y. и др. Catheter-Directed Thrombolysis Versus Standard Anticoagulation for Acute Lower Extremity Deep Vein Thrombosis: A Meta-Analysis of Clinical Trials.//Clin. Appl. Thromb. Hemost. SAGE Publications Sage CA: Los Angeles, CA, 2018. Т. 24, N 7. С. 1134 - 1143.

269. Foegh P. и др. Editor's Choice - Factors Associated with Long-Term Outcome in 191 Patients with Ilio-Femoral DVT Treated With Catheter-Directed Thrombolysis.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2017. Т. 53, N 3. С. 419 - 424.

270. Безлепкин Ю.А. и др. Сравнение отдаленных результатов регионарного катетерного тромболизиса и стандартного консервативного лечения при проксимальных тромбозах глубоких вен нижних конечностей//Флебология. 2020. Т. 14, N 1.

271. Razavi M.K. и др. Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial.//J. Vasc. Interv. Radiol. Elsevier, 2020. Т. 31, N 10. С. 1517 - 1528.e2.

272. Huang C., Zhang W., Liang H. A retrospective comparison of thrombectomy followed by stenting and thrombectomy alone for the management of deep vein thrombosis with May-Thurner syndrome.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2021. Т. 9, N 3. С. 635 - 642.

273. Лобастов К.В. и др. Диагностика и лечение хронической венозной обструкции: согласованное мнение российских экспертов (часть 2)//Хирург. Общество с ограниченной ответственностью Издательский дом Панорама, 2020. N 7 - 8. С. 22 - 55.

274. Comerota A.J. и др. Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis.//Circulation. Am Heart Assoc, 2019. Т. 139, N 9. С. 1162 - 1173.

275. Kearon C. и др. Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral-Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial//Thromb. Haemost. Georg Thieme Verlag KG, 2019. Т. 119, N 04. С. 633 - 644.

276. Notten P., Ten Cate H., Ten Cate-Hoek A.J. Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review.//J. Thromb. Haemost. Wiley Online Library, 2021. Т. 19, N 3. С. 753 - 796.

277. Sebastian T. и др. Cessation of anticoagulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.//Vasa. Hogrefe AG, 2019. Т. 48, N 4. С. 331 - 339.

278. Limone B.L. и др. Timing of recurrent venous thromboembolism early after the index event: a meta-analysis of randomized controlled trials.//Thromb. Res. Elsevier, 2013. Т. 132, N 4. С. 420 - 426.

279. Kearon C. и др. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.//Chest. Elsevier, 2016. Т. 149, N 2. С. 315 - 352.

280. Kearon C., Kahn S.R. Long-term treatment of venous thromboembolism.//Blood. American Society of Hematology Washington, DC, 2020. Т. 135, N 5. С. 317 - 325.

281. Heit J.A. и др. Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study.//Thromb. Res. Elsevier, 2015. Т. 136, N 2. С. 298 - 307.

282. Douketis J. и др. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.//Ann. Intern. Med. American College of Physicians, 2010. Т. 153, N 8. С. 523 - 531.

283. Kearon C. и др. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.//Ann. Intern. Med. American College of Physicians, 2015. Т. 162, N 1. С. 27 - 34.

284. Donadini M.P. и др. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.//Thromb. Haemost. Schattauer GmbH, 2014. Т. 111, N 1. С. 172 - 179.

285. Prandoni P. и др. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.//Ann. Intern. Med. American College of Physicians, 2002. Т. 137, N 12. С. 955 - 960.

286. Prandoni P. и др. Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants.//Thromb. Res. Elsevier, 2017. Т. 153. С. 97 - 100.

287. Siragusa S. и др. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study.//Blood. American Society of Hematology Washington, DC, 2008. Т. 112, N 3. С. 511 - 515.

288. Lobastov K. и др. Electrical calf muscle stimulation in patients with post-thrombotic syndrome and residual venous obstruction after anticoagulation therapy.//Int. Angiol. 2018. Т. 37, N 5. С. 400 - 410.

289. Zhu T., Martinez I., Emmerich J. Venous thromboembolism: Risk factors for recurrence//Arterioscler. Thromb. Vasc. Biol. Am Heart Assoc, 2009. Т. 29, N 3. С. 298 - 310.

290. Palareti G. Recurrent venous thromboembolism: what is the risk and how to prevent it.//Scientifica (Cairo). 2012. Т. 2012. С. 391734.

291. Ho W.K. и др. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.//Arch. Intern. Med. American Medical Association, 2006. Т. 166, N 7. С. 729 - 736.

292. , Kevane B. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?//Blood Adv. American Society of Hematology Washington, DC, 2020. Т. 4, N 21. С. 5595 - 5606.

293. Mannucci P.M., Franchini M. Classic thrombophilic gene variants.//Thromb. Haemost. Schattauer GmbH, 2015. Т. 114, N 5. С. 885 - 889.

294. Croles F.N. и др. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis//BMJ. British Medical Journal Publishing Group, 2017. Т. 359. С. j4452.

295. van Vlijmen E.F.W. и др. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.//J. Thromb. Haemost. Wiley Online Library, 2016. Т. 14, N 7. С. 1393 - 1403.

296. Campello E. и др. Thrombophilia, risk factors and prevention.//Expert Rev. Hematol. Taylor & Francis, 2019. Т. 12, N 3. С. 147 - 158.

297. Marcucci M. и др. Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data.//J. Thromb. Haemost. Wiley Online Library, 2015. Т. 13, N 5. С. 775 - 781.

298. Klok F.A., Huisman M. V. How I assess and manage the risk of bleeding in patients treated for venous thromboembolism.//Blood. American Society of Hematology Washington, DC, 2020. Т. 135, N 10. С. 724 - 734.

299. Marques Antunes M. и др. The high-risk bleeding category of different scores in patients with venous thromboembolism: Systematic review and meta-analysis.//Eur. J. Intern. Med. Elsevier, 2021. Т. 94. С. 45 - 55.

300. Hindricks G. и др. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the Europea//Eur. Heart J. Oxford University Press, 2021. Т. 42, N 5. С. 373 - 498.

301. Steffel J., Heidb chel H. 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment-Authors' reply//EP Eur. 2021. Т. 23, N 10. С. 1685 - 1686.

302. Schulman S. и др. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.//J. Thromb. Haemost. Wiley Online Library, 2010. Т. 8, N 1. С. 202 - 204.

303. Schulman S., Kearon C., Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.//J. Thromb. Haemost. 2005. Т. 3, N 4. С. 692 - 694.

304. Kaatz S. и др. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.//J. Thromb. Haemost. 2015. Т. 13, N 11. С. 2119 - 2126.

305. Boutitie F. и др. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.//BMJ. British Medical Journal Publishing Group, 2011. Т. 342, N may24 2. С. d3036.

306. Nieto J.A. и др. Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurely.//Thromb. Res. Elsevier, 2020. Т. 189. С. 61 - 68.

307. Middeldorp S., Prins M.H., Hutten B.A. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2014. Т. 2014, N 8. С. CD001367.

308. Punthakee X., Doobay J., Anand S.S. Oral-anticoagulant-related intracerebral hemorrhage.//Thromb. Res. Elsevier, 2002. Т. 108, N 1. С. 31 - 36.

309. Linkins L.-A., Choi P.T., Douketis J.D. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.//Ann. Intern. Med. 2003. Т. 139, N 11. С. 893 - 900.

310. Carrier M. и др. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.//Ann. Intern. Med. American College of Physicians, 2010. Т. 152, N 9. С. 578 - 589.

311. Ebraheem M. и др. Extended DOAC therapy in patients with VTE and potential risk of recurrence: A systematic review and meta-analysis.//J. Thromb. Haemost. Wiley Online Library, 2020. Т. 18, N 9. С. 2308 - 2317.

312. Петриков А.С. и др. Прогресс реканализации глубоких вен нижних конечностей на фоне пролонгированной антитромботической терапии и содержание D-димеров, C-реактивного белка и гомоцистеина.//Флебология. 2020. Т. 14, N 3.

313. Agnelli G. и др. Apixaban for extended treatment of venous thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2013. Т. 368, N 8. С. 699 - 708.

314. Weitz J.I. и др. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2017. Т. 376, N 13. С. 1211 - 1222.

315. Becattini C. и др. Aspirin for preventing the recurrence of venous thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2012. Т. 366, N 21. С. 1959 - 1967.

316. Воробьева Н.М., Панченко, Е.П. Продленная антикоагулянтная терапия у пациентов, переживших тромбоэмболию легочных артерий//Атеротромбоз. 2018. N 2. С. 36 - 45.

317. Brighton T.A. и др. Low-dose aspirin for preventing recurrent venous thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2012. Т. 367, N 21. С. 1979 - 1987.

318. Simes J. и др. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.//Circulation. 2014. Т. 130, N 13. С. 1062 - 1071.

319. Королева В. и др. Место ривароксабана в лечении и продленной профилактике рецидивов ВТЭО у пациентов с тромбоэмболией легочных артерий.//Флебология. 2021. Т. 15, N 3.

320. Mai V. и др. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.//PLoS One / под ред. Dias S. Public Library of Science San Francisco, CA USA, 2019. Т. 14, N 4. С. e0214134.

321. Jiang Q.-J. и др. Sulodexide for Secondary Prevention of Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis.//Front. Pharmacol. Frontiers, 2018. Т. 9. С. 876.

322. Franco L. и др. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.//J. Thromb. Haemost. Wiley Online Library, 2017. Т. 15, N 6. С. 1142 - 1154.

323. Bradbury C. и др. A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the Ex//Br. J. Haematol. Wiley Online Library, 2020. Т. 188, N 6. С. 962 - 975.

324. Aziz D. и др. Long term risk of recurrent venous thromboembolism after a first contraceptive related event: Data from REVERSE cohort study//J. Thromb. Haemost. Wiley Online Library, 2021. Т. 19, N 6. С. 1526 - 1532.

325. White R.H., Murin S., Wun T. Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism//J. Thromb. Haemost. Schattauer GmbH, 2010. Т. 8, N 5. С. 987 - 997.

326. Le Gal G. и др. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.//Thromb. Haemost. Schattauer GmbH, 2010. Т. 104, N 3. С. 498 - 503.

327. Vaillant-Roussel H. и др. Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives.//Contraception. Elsevier, 2011. Т. 84, N 5. С. e23 - 30.

328. Martinelli I., Lensing A.W.A., Middeldorp S. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use//Blood. American Society of Hematology Washington, DC, 2016. Т. 127, N 11. С. 1417 - 1425.

329. Ageno W. и др. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE.//Res. Pract. Thromb. Haemost. Wiley Online Library, 2021. Т. 5, N 2. С. 326 - 341.

330. Djulbegovic M., Lee A.I., Chen K. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta analysis, and decision analysis//J. Eval. Clin. Pract. Wiley Online Library, 2020. Т. 26, N 1. С. 7 - 17.

331. Kahn S.R.S., Julian J.J.A., Kearon C. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis//J. Vasc. Surg. Venous Lymphat. Disord. Elsevier, 2020. Т. 8, N 1. С. 8 - 23.

332. Robertson L., Yeoh S.E., Ramli A. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2017. Т. 12, N 12. С. CD011088.

333. Schulman S. и др. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.//N. Engl. J. Med. Mass Medical Soc, 1997. Т. 336, N 6. С. 393 - 398.

334. Kahale L.A. и др. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2018. Т. 6, N 6. С. CD006650.

335. Marshall A. и др. Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m).//J. Thromb. Haemost. Wiley Online Library, 2020. Т. 18, N 4. С. 905 - 915.

336. Dufrost V., Wahl D., Zuily S. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.//Autoimmun. Rev. Elsevier, 2021. Т. 20, N 1. С. 102711.

337. Schulman S., Svenungsson E., Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.//Am. J. Med. Elsevier, 1998. Т. 104, N 4. С. 332 - 338.

338. Kirkilesis G. и др. Treatment of distal deep vein thrombosis.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2020. Т. 4, N 4. С. CD013422.

339. Hokusai-VTE Investigators и др. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2013. Т. 369, N 15. С. 1406 - 1415.

340. Pesavento R. и др. Fondaparinux in the initial and long-term treatment of venous thromboembolism//Thromb. Res. Elsevier, 2015. Т. 135, N 2. С. 311 - 317.

341. Cohen A.T. и др. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.//PLoS One. Public Library of Science San Francisco, CA USA, 2015. Т. 10, N 12. С. e0144856.

342. Agnelli G. и др. Oral apixaban for the treatment of acute venous thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2013. Т. 369, N 9. С. 799 - 808.

343. EINSTEIN Investigators и др. Oral rivaroxaban for symptomatic venous thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2010. Т. 363, N 26. С. 2499 - 2510.

344. EINSTEIN-PE Investigators и др. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.//N. Engl. J. Med. Mass Medical Soc, 2012. Т. 366, N 14. С. 1287 - 1297.

345. Schulman S. и др. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.//Circulation. Am Heart Assoc, 2014. Т. 129, N 7. С. 764 - 772.

346. Amin A. и др. Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients//J. Med. Econ. Taylor & Francis, 2014. Т. 17, N 11. С. 763 - 770.

347. Law S. и др. A pharmacoeconomic study of traditional anticoagulation versus direct oral anticoagulation for the treatment of venous thromboembolism in the emergency department.//CJEM. Cambridge University Press, 2016. Т. 18, N 5. С. 340 - 348.

348. Amin A. и др. Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States//Clin. Appl. Thromb. SAGE Publications Sage CA: Los Angeles, CA, 2016. Т. 22, N 1. С. 5 - 11.

349. Millar C.M., Laffan M.A. Drug therapy in anticoagulation: which drug for which patient?//Clin. Med. Royal College of Physicians, 2017. Т. 17, N 3. С. 233 - 244.

350. Smith S.B. и др. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism.//Chest. Elsevier, 2010. Т. 137, N 6. С. 1382 - 1390.

351. Quinlan D.J., McQuillan A., Eikelboom J.W. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.//Ann. Intern. Med. American College of Physicians, 2004. Т. 140, N 3. С. 175 - 183.

352. Robertson L., Jones L.E. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2017. Т. 2, N 2. С. CD001100.

353. Robertson L., Strachan J. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2017. Т. 2, N 2. С. CD006771.

354. Cossette B., Pelletier M.-., Carrier N. Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular weight heparin: a cohort study in the context of a quality improvement initiative//Ann. Pharmacother. SAGE Publications Sage CA: Los Angeles, CA, 2010. Т. 44, N 6. С. 994 - 1002.

355. Prandoni P. и др. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study.//Blood. American Society of Hematology, 2005. Т. 106, N 9. С. 3049 - 3054.

356. Meyer G. и др. Fibrinolysis for patients with intermediate-risk pulmonary embolism.//N. Engl. J. Med. Mass Medical Soc, 2014. Т. 370, N 15. С. 1402 - 1411.

357. Vedantham S. и др. Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal.//J. Vasc. Interv. Radiol. Elsevier Inc., 2014. Т. 25, N 9. С. 1317 - 1325.

358. Graif A. и др. Safety of Therapeutic Anticoagulation with Low-Molecular-Weight Heparin or Unfractionated Heparin Infusion during Catheter-Directed Thrombolysis for Acute Pulmonary Embolism.//J. Vasc. Interv. Radiol. Elsevier, 2020. Т. 31, N 4. С. 537 - 543.

359. Li Y., Wang J., He R. Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis//Thromb. J. Springer, 2021. Т. 19, N 1. С. 1 - 7.

360. Hull R.D. и др. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.//Arch. Intern. Med. American Medical Association, 1997. Т. 157, N 22. С. 2562 - 2568.

361. Kakkar V. V и др. Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis//Thromb. Haemost. Schattauer GmbH, 2003. Т. 89, N 04. С. 674 - 680.

362. Lecumberri R. и др. Fixed dose low molecular weight heparin, bemiparin, in the long term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: the FLEBUS study//J. Thromb. Haemost. Elsevier, 2006. Т. 4, N 11. С. 2504 - 2508.

363. и др. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.//Ann. Intern. Med. American College of Physicians, 2004. Т. 140, N 11. С. 867 - 873.

364. Warkentin T.E., Maurer B.T., Aster R.H. Heparin-Induced Thrombocytopenia associated with fondaparinux//N. Engl. J. Med. 2007. Т. 356, N 25. С. 2653 - 2655.

365. Konstantinides S. V и др. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)//Eur. Heart J. Oxford University Press, 2014. Т. 35, N 43. С. 3033 - 3080.

366. Barginear M.F. и др. Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial.//Support. Care Cancer. Springer, 2012. Т. 20, N 11. С. 2865 - 2872.

367. Bhatt V.R. и др. Fondaparinux-associated heparin-induced thrombocytopenia.//Eur. J. Haematol. Wiley Online Library, 2013. Т. 91, N 5. С. 437 - 441.

368. Savi P. и др. Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin.//Blood. American Society of Hematology, 2005. Т. 105, N 1. С. 139 - 144.

369. Warkentin T.E. и др. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.//J. Thromb. Haemost. Wiley Online Library, 2011. Т. 9, N 12. С. 2389 - 2396.

370. Schindewolf M. и др. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.//Thromb. Res. Elsevier, 2014. Т. 134, N 1. С. 29 - 35.

371. Kang M. и др. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study.//Blood. American Society of Hematology Washington, DC, 2015. Т. 125, N 6. С. 924 - 929.

372. Lobo B. и др. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.//Thromb. Haemost. Schattauer GmbH, 2008. Т. 99, N 1. С. 208 - 214.

373. Benken S.T. и др. A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients.//J. Cardiothorac. Surg. BioMed Central, 2014. Т. 9, N 1. С. 55.

374. Cegarra-Sanmart n V. и др. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.//J. Cardiothorac. Vasc. Anesth. Elsevier, 2014. Т. 28, N 4. С. 1008 - 1012.

375. Posters Abstracts//Res. Pract. Thromb. Haemost. 2020. Т. 4, N S1. С. 1 - 1311.

376. Воробьева Н.А., Воробьева А.И., Шемякина Н.Я. Пациент-ориентированный подход как основа повышения эффективности и безопасности антитромботической терапии у коморбидных пациентов. Роль антикоагулянтных кабинетов//Клиническая геронтология. Общество с ограниченной ответственностью "Медико-технологическое предприятие..., 2019. Т. 25, N 11 - 12.

377. Liu M., Zhang F. Administration routes affect thrombolytic effect of catheter-directed thrombolysis with pro-urokinase in treating deep vein thrombosis.//Ann. Transl. Med. AME Publications, 2018. Т. 6, N 16. С. 322.

378. Kearon C. и др. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 1999. Т. 340, N 12. С. 901 - 907.

379. Ridker P.M. и др. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2003. Т. 348, N 15. С. 1425 - 1434.

380. Raskob G. и др. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.//Lancet. Haematol. Elsevier, 2016. Т. 3, N 5. С. e228-36.

381. Schulman S. и др. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2013. Т. 368, N 8. С. 709 - 718.

382. Andreozzi G.M. и др. Sulodexide for the Prevention of Recurrent Venous Thromboembolism//Circulation. Am Heart Assoc, 2015. Т. 132, N 20. С. 1891 - 1897.

383. Andras A., Sala Tenna A., Stewart M. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism//Cochrane Database Syst. Rev. John Wiley & Sons, Ltd, 2017. Т. 2017, N 7. С. CD002001.

384. Iorio A., Guercini F., Pini M. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.//J. Thromb. Haemost. Wiley Online Library, 2003. Т. 1, N 9. С. 1906 - 1913.

385. Hull R.D., Liang J., Townshend G. Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review.//Am. J. Med. Elsevier, 2011. Т. 124, N 8. С. 756 - 765.

386. и др. Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism.//Pathophysiol. Haemost. Thromb. Karger Publishers, 2003. Т. 33, N 2. С. 64 - 67.

387. Linkins L.-A. и др. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.//Chest. Elsevier, 2012. Т. 141, N 2 Suppl. С. e495S-e530S.

388. Pompilio G. и др. Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism: A Bayesian Network Meta-analysis//TH Open. Georg Thieme Verlag KG, 2020. Т. 04, N 02. С. e80-e93.

389. Савельев В.С., Гологорский В.А., Кириенко А.И. Флебология. 2001.

390. Gloviczki P. Handbook of venous and lymphatic disorders: guidelines of the American Venous Forum. CRC Press, 2017.

391. Kearon C. и др. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative.//Ann. Intern. Med. American College of Physicians, 1998. Т. 128, N 8. С. 663 - 677.

392. Messina L.M. и др. Clinical significance of routine imaging of iliac and calf veins by color flow duplex scanning in patients suspected of having acute lower extremity deep venous thrombosis.//Surgery. 1993. Т. 114, N 5. С. 921 - 927.

393. Sampson F., Goodacre S., Thomas S. The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis//Eur. Radiol. Eur Radiol, 2007. Т. 17, N 1. С. 175 - 181.

394. Thomas S., Goodacre S., Sampson F. Diagnostic value of CT for deep vein thrombosis: results of a systematic review and meta-analysis//Clin. Radiol. Clin Radiol, 2008. Т. 63, N 3. С. 299 - 304.

395. AbuRahma A.F.A. и др. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting//Ann. Surg. Lippincott, Williams, and Wilkins, 2001. Т. 233, N 6. С. 752.

396. Baekgaard N. и др. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2010. Т. 39, N 1. С. 112 - 117.

397. Notten P. и др. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial.//Lancet. Haematol. 2020. Т. 7, N 1. С. e40 - e49.

398. Enden T., Haig Y., Kl w N.N.-E. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial//Lancet (London, England). Lancet, 2012. Т. 379, N 9810. С. 31 - 38.

399. Sharifi M., Bay C., Mehdipour M. Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion (TORPEDO) trial: midterm results//J. Endovasc. Ther. J Endovasc Ther, 2012. Т. 19, N 2. С. 273 - 280.

400. Vedantham S., Goldhaber S.S.Z., Julian J.J.A. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis//N. Engl. J. Med. Mass Medical Soc, 2017. Т. 377, N 23. С. 2240 - 2252.

401. Sharifi M., Mehdipour M., Bay, CSmith G. Endovenous therapy for deep venous thrombosis: the TORPEDO trial//Catheter. Cardiovasc. Interv. Catheter Cardiovasc Interv, 2010. Т. 76, N 3. С. 316 - 325.

402. Protack C.D. и др. Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement.//J. Vasc. Surg. Elsevier, 2007. Т. 45, N 5. С. 992-997; discussion 997.

403. Mewissen M.W. и др. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry.//Radiology. Radiological Society of North America, 1999. Т. 211, N 1. С. 39 - 49.

404. Lin P.P.H., Zhou W., Dardik A. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis//Am. J. Surg. Elsevier, 2006. Т. 192, N 6. С. 782 - 788.

405. Arko F.R., Davis C.C.M., Murphy E.E.H. Aggressive percutaneous mechanical thrombectomy of deep venous thrombosis: early clinical results//Arch. Surg. American Medical Association, 2007. Т. 142, N 6. С. 513 - 518.

406. Martinez Trabal J., Comerota A.A.J., LaPorte F.F.B.F. The quantitative benefit of isolated, segmental, pharmacomechanical thrombolysis (ISPMT) for iliofemoral venous thrombosis//J. Vasc. Surg. Elsevier, 2008. Т. 48, N 6. С. 1532 - 1537.

407. Tsai J., Georgiades C.C.S., Hong K. Presumed pulmonary embolism following power-pulse spray thrombectomy of upper extremity venous thrombosis//Cardiovasc. Intervent. Radiol. Springer, 2006. Т. 29, N 4. С. 678 - 680.

408. Eklof B., Mclafferty R.B. Surgical thrombectomy and percutaneous mechanical thrombectomy for treatment of acute iliofemoral venous thrombosis//Handbook of Venous Disorders: Guidelines of the American Venous Forum Third Edition. CRC Press, 2008. С. 255.

409. Vedantham S. и др. Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal.//J. Vasc. Interv. Radiol. 2014. Т. 25, N 9. С. 1317 - 1325.

410. Ashrafi M. и др. Treatment Strategies for Proximal Deep Vein Thrombosis: A Network Meta-analysis of Randomised Controlled Trials.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2022. Т. 63, N 2. С. 323 - 334.

411. Casey E.T. и др. Treatment of acute iliofemoral deep vein thrombosis.//J. Vasc. Surg. J Vasc Surg, 2012. Т. 55, N 5. С. 1463 - 1473.

412. Лебедев И.С. и др. Фармакомеханическая реканализация магистральных вен при синей флегмазии, вызванной эмболической окклюзией кава-фильтра//Флебология. 2020. Т. 14, N 1.

413. Plate G., Ekl f B., Norgren L. Venous thrombectomy for iliofemoral vein thrombosis--10-year results of a prospective randomised study//Eur. J. Vasc. Endovasc. Surg. Eur J Vasc Endovasc Surg, 1997. Т. 14, N 5. С. 367 - 374.

414. Rodr guez L., Aboukheir-Aboukheir A., Figueroa-Vicente R. Hybrid operative thrombectomy is noninferior to percutaneous techniques for the treatment of acute iliofemoral deep venous thrombosis//J. Vasc. surgery. Venous Lymphat. Disord. J Vasc Surg Venous Lymphat Disord, 2017. Т. 5, N 2. С. 177 - 184.

415. Karthikesalingam A. и др. A systematic review of percutaneous mechanical thrombectomy in the treatment of deep venous thrombosis.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2011. Т. 41, N 4. С. 554 - 565.

416. Bl ttler W., Heller G., Largiad r J. Combined regional thrombolysis and surgical thrombectomy for treatment of iliofemoral vein thrombosis//J. Vasc. Surg. Elsevier, 2004. Т. 40, N 4. С. 620 - 625.

417. Comerota A.A.J., Gale S.S. Technique of contemporary iliofemoral and infrainguinal venous thrombectomy//J. Vasc. Surg. Elsevier, 2006. Т. 43, N 1. С. 185 - 191.

418. и др. Longterm results after surgical thrombectomy and simultaneous stenting for symptomatic iliofemoral venous thrombosis.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2010. Т. 39, N 3. С. 349 - 355.

419. Husmann M.J. и др. Stenting of common iliac vein obstructions combined with regional thrombolysis and thrombectomy in acute deep vein thrombosis.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2007. Т. 34, N 1. С. 87 - 91.

420. Lindow C. и др. Long-term results after transfemoral venous thrombectomy for iliofemoral deep venous thrombosis.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2010. Т. 40, N 1. С. 134 - 138.

421. Schwarzbach M.H.M. и др. Surgical Thrombectomy Followed by Intraoperative Endovascular Reconstruction for Symptomatic Ilio-femoral Venous Thrombosis//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2005. Т. 29, N 1. С. 58 - 66.

422. Lichtenberg M.K.W. и др. Endovascular mechanical thrombectomy versus thrombolysis in patients with iliofemoral deep vein thrombosis - a systematic review and meta-analysis.//Vasa. Hogrefe AG, 2021. Т. 50, N 1. С. 59 - 67.

423. Hull R.D. и др. Quantitative assessment of thrombus burden predicts the outcome of treatment for venous thrombosis: a systematic review.//Am. J. Med. 2005. Т. 118, N 5. С. 456 - 464.

424. Haig Y. и др. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial.//Lancet. Haematol. Elsevier, 2016. Т. 3, N 2. С. e64 - 71.

425. Engelberger R.P. и др. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial.//J. Thromb. Haemost. Am Heart Assoc, 2017. Т. 15, N 7. С. 1351 - 1360.

426. Garcia M., Lookstein R., Malhotra R. Endovascular Management of Deep Vein Thrombosis with Rheolytic Thrombectomy: Final Report of the Prospective Multicenter PEARL (Peripheral Use of AngioJet Rheolytic Thrombectomy with a Variety of Catheter Lengths) Registry//J. Vasc. Interv. Radiol. J Vasc Interv Radiol, 2015. Т. 26, N 6. С. 777 - 785.

427. Goldhaber S.Z. и др. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis.//Am. J. Med. Elsevier, 1984. Т. 76, N 3. С. 393 - 397.

428. Schwieder G. и др. Intermittent regional therapy with rt-PA is not superior to systemic thrombolysis in deep vein thrombosis (DVT)--a German multicenter trial.//Thromb. Haemost. Schattauer GmbH, 1995. Т. 74, N 5. С. 1240 - 1243.

429. Watson L., Broderick C., Armon M.P. Thrombolysis for acute deep vein thrombosis.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2016. Т. 11, N 11. С. CD002783.

430. Vedantham S., Thorpe P.P.E., Cardella J.J.F. Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal//J. Vasc. Interv. Radiol. Elsevier Inc., 2009. Т. 20, N 7 Suppl. С. 227 - 239.

431. N., Klitfod L., Broholm R. Safety and efficacy of catheter-directed thrombolysis//Phlebology. SAGE Publications Sage UK: London, England, 2012. Т. 27, N 1_suppl. С. 149 - 154.

432. B kgaard N., Klitfod L., J rgensen M. Should catheter-directed thrombolysis be monitored?//Phlebology. SAGE Publications Sage UK: London, England, 2016. Т. 31, N 1_suppl. С. 5 - 10.

433. Chaar C.I.O. Current Management of Venous Diseases/под ред. Chaar C.I.O. Cham: Springer International Publishing, 2018.

434. Kohi M.M.P., Kohlbrenner R., Kolli K.K.P. Catheter directed interventions for acute deep vein thrombosis//Cardiovasc. Diagn. Ther. AME Publications, 2016. Т. 6, N 6. С. 599.

435. Watson L., Armon M. Thrombolysis for acute deep vein thrombosis//Cochrane database Syst. Rev. Cochrane Database Syst Rev, 2004. N 4.

436. Jeyabalan G. и др. Inflow thrombosis does not adversely affect thrombolysis outcomes of symptomatic iliofemoral deep vein thrombosis.//J. Vasc. Surg. Elsevier, 2011. Т. 54, N 2. С. 448 - 453.

437. Grunwald M.R., Hofmann L. V. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis.//J. Vasc. Interv. Radiol. Elsevier, 2004. Т. 15, N 4. С. 347 - 352.

438. Sugimoto K., Hofmann L.V.L., Razavi M.M.K. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions//J. Vasc. Surg. Elsevier, 2003. Т. 37, N 3. С. 512 - 517.

439. Sillesen H. и др. Catheter directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2005. Т. 30, N 5. С. 556 - 562.

440. Verhaeghe R. и др. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA.//Eur. Radiol. Springer, 1997. Т. 7, N 7. С. 996 - 1001.

441. Engelberger R.P. и др. Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis.//Thromb. Haemost. Schattauer GmbH, 2014. Т. 111, N 6. С. 1153 - 1160.

442. Comerota A.J. The ATTRACT Trial: Rationale for Early Intervention for Iliofemoral DVT//Perspect. Vasc. Surg. Endovasc. Ther. Sage Publications Sage CA: Los Angeles, CA, 2009. Т. 21, N 4. С. 221 - 225.

443. Semba C.P. и др. Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy.//J. Vasc. Interv. Radiol. 2000. Т. 11, N 3. С. 279 - 287.

444. Ogawa T., Hoshino S., Midorikawa H. Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with acute proximal venous thrombosis of the leg//J. Vasc. Surg. Elsevier, 2005. Т. 42, N 5. С. 940 - 944.

445. Vedantham S. и др. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis.//J. Vasc. Interv. Radiol. Elsevier, 2004. Т. 15, N 6. С. 565 - 574.

446. Bush R.L. и др. Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study.//J. Vasc. Surg. Elsevier, 2004. Т. 40, N 5. С. 965 - 970.

447. Kim H.S. и др. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes.//J. Vasc. Interv. Radiol. Elsevier, 2006. Т. 17, N 7. С. 1099 - 1104.

448. Diniz J., Coelho A., Mansilha A. Endovascular treatment of iliofemoral deep venous thrombosis: is there enough evidence to support it? A systematic review with meta-analysis//Int. Angiol. 2020. Т. 39, N 2.

449. Escobar G.A.G., Burks D., Abate M.M.R.M. Risk of acute kidney injury after percutaneous pharmacomechanical thrombectomy using AngioJet in venous and arterial thrombosis//Ann. Vasc. Surg. Elsevier, 2017. Т. 42. С. 238 - 245.

450. Shen Y., Wang X., Jin S.S. Increased risk of acute kidney injury with percutaneous mechanical thrombectomy using AngioJet compared with catheter-directed thrombolysis//J. Vasc. Surg. Venous Lymphat. Disord. Elsevier, 2019. Т. 7, N 1. С. 29-37.

451. Morrow K.K.L., Kim A.A.H., Plato S. Increased risk of renal dysfunction with percutaneous mechanical thrombectomy compared with catheter-directed thrombolysis//J. Vasc. Surg. Elsevier, 2017. Т. 65, N 5. С. 1460-1466.

452. Minko P. и др. Mechanical thrombectomy of iliac vein thrombosis in a pig model using the Rotarex and Aspirex catheters.//Cardiovasc. Intervent. Radiol. Springer, 2014. Т. 37, N 1. С. 211 - 217.

453. Lichtenberg M., Stahlhoff W., zkapi A. Safety, procedural success and outcome of the Aspirex (R) S endovascular thrombectomy system in the treatment of iliofemoral deep vein thrombosis - data from the Arnsberg Aspirex registry//Vasa. Vasa, 2019. Т. 48, N 4. С. 341 - 346.

454. Loffroy R., Falvo N., Guillen K. Single-Session Percutaneous Mechanical Thrombectomy Using the Aspirex(R) S Device Plus Stenting for Acute Iliofemoral Deep Vein Thrombosis: Safety, Efficacy, and Mid-Term Outcomes//Diagnostics. Multidisciplinary Digital Publishing Institute, 2020. Т. 10, N 8. С. 544.

455. , Strube H., Sadeghi-Azandaryani M. Rotational thrombectomy of acute peripheral vascular occlusions using the ThromCat XT device: techniques, indications and initial results//Diagnostic Interv. Radiol. Aves Yayincilik Ltd. STI., 2011. Т. 17, N 3. С. 283.

456. Delomez M. и др. Mechanical thrombectomy in patients with deep venous thrombosis.//Cardiovasc. Intervent. Radiol. Springer, 2001. Т. 24, N 1. С. 42 - 48.

457. Gandini R. и др. Percutaneous ilio-caval thrombectomy with the Amplatz device: preliminary results.//Eur. Radiol. Springer, 1999. Т. 9, N 5. С. 951 - 958.

458. Lee K.-H. и др. Mechanical thrombectomy of acute iliofemoral deep vein thrombosis with use of an Arrow-Trerotola percutaneous thrombectomy device.//J. Vasc. Interv. Radiol. Elsevier, 2006. Т. 17, N 3. С. 487 - 495.

459. Прозоров С.А. и др. Удаление флотирующих тромбов из нижней полой вены//Эндоваскулярная хирургия. Общероссийская общественная организация" Российское научное общество..., 2017. Т. 4, N 1. С. 39 - 44.

460. Капранов С.А. Эндоваскулярная хирургия при заболеваниях венозной системы: возможности и перспективы//Флебология. 2007. Т. 1, N 1. С. 29.

461. Rajput F., Du L., Woods M. Percutaneous vacuum-assisted thrombectomy using angioVac aspiration system//Cardiovasc. Revascularization Med. Elsevier, 2020. Т. 21, N 4. С. 489 - 493.

462. Lopez R., DeMartino R., Fleming M. Aspiration thrombectomy for acute iliofemoral or central deep venous thrombosis//J. Vasc. Surg. Venous Lymphat. Disord. Elsevier, 2019. Т. 7, N 2. С. 162 - 168.

463. Hariri A. и др. Use of a novel mechanical rinsing and aspiration thrombectomy device for treatment of deep venous and arteriovenous graft thrombosis.//J. Vasc. Interv. Radiol. Elsevier, 2007. Т. 18, N 2. С. 313 - 316.

464. Wang W., Sun R., Chen Y. Meta-analysis and systematic review of percutaneous mechanical thrombectomy for lower extremity deep vein thrombosis//J. Vasc. Surg. Venous Lymphat. Disord. Elsevier, 2018. Т. 6, N 6. С. 788 - 800.

465. Alkhouli M. и др. Inferior Vena Cava Thrombosis//JACC Cardiovasc. Interv. American College of Cardiology Foundation Washington, DC, 2016. Т. 9, N 7. С. 629 - 643.

466. McAree B.J. и др. Inferior vena cava thrombosis: a review of current practice.//Vasc. Med. Sage Publications Sage UK: London, England, 2013. Т. 18, N 1. С. 32 - 43.

467. Kaufman J.A. и др. Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease: Developed in collaboration with the American College of Cardiology, American College of Chest P//J. Vasc. Interv. Radiol. Elsevier, 2020. Т. 31, N 10. С. 1529 - 1544.

468. Stein P.D., Matta F., Yaekoub A.Y. Incidence of vena cava thrombosis in the United States.//Am. J. Cardiol. Elsevier, 2008. Т. 102, N 7. С. 927 - 929.

469. Sharifi M. и др. Role of IVC filters in endovenous therapy for deep venous thrombosis: the FILTER-PEVI (filter implantation to lower thromboembolic risk in percutaneous endovenous intervention) trial.//Cardiovasc. Intervent. Radiol. Springer, 2012. Т. 35, N 6. С. 1408 - 1413.

470. Avgerinos E.D. и др. Inferior vena cava filter placement during thrombolysis for acute iliofemoral deep venous thrombosis.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2014. Т. 2, N 3. С. 274 - 281.

471. Black S.A. и др. Management of acute and chronic iliofemoral venous outflow obstruction: a multidisciplinary team consensus.//Int. Angiol. Edizioni Minerva Medica, 2020. Т. 39, N 1. С. 3 - 16.

472. Chick J.F.B. и др. Endovascular Iliocaval Stent Reconstruction for Inferior Vena Cava Filter-Associated Iliocaval Thrombosis: Approach, Technical Success, Safety, and Two-Year Outcomes in 120 Patients.//J. Vasc. Interv. Radiol. Elsevier, 2017. Т. 28, N 7. С. 933 - 939.

473. Group P.S. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study//Circulation. Am Heart Assoc, 2005. Т. 112, N 3. С. 416 - 422.

474. и др. Thrombus embolization into IVC filters during catheter-directed thrombolysis for proximal deep venous thrombosis.//J. Endovasc. Ther. SAGE Publications Sage CA: Los Angeles, CA, 2008. Т. 15, N 5. С. 605 - 613.

475. Лебедев И.С. и др. Тромбоз нижней полой вены, исходящий из гонадных вен, в послеродовом периоде: описание серии случаев и обзор литературы.//Флебология. 2020. Т. 14, N 3.

476. Meissner M.H. и др. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.//J. Vasc. Surg. Elsevier, 2012. Т. 55, N 5. С. 1449 - 1462.

477. Weaver F.A. и др. Phlegmasia cerulea dolens: therapeutic considerations.//South. Med. J. 1988. Т. 81, N 3. С. 306 - 312.

478. Fasolini F.G., Streuli H.K. [Thrombectomy versus conservative therapy of thrombosis of the deep veins of the pelvis and legs. Late results 10 years later].//Helv. Chir. Acta. 1985. Т. 52, N 5. С. 735 - 738.

479. и др. Surgical thrombectomy versus conservative treatment for deep venous thrombosis; functional comparison of long-term results.//Eur. J. Vasc. Surg. Elsevier, 1989. Т. 3, N 6. С. 529 - 538.

480. Hamilton H. и др. Venous thrombectomy in patients presenting with iliofemoral vein thrombosis after renal transplantation.//Transpl. Int. Wiley Online Library, 1996. Т. 9, N 5. С. 513 - 516.

481. Hold M. и др. Deep venous thrombosis: results of thrombectomy versus medical therapy. Presented at the 5th European-American Symposium on Venous Diseases, Vienna, Austria, Nov. 7 - 11, 1990.//Vasa. 1992. Т. 21, N 2. С. 181 - 187.

482. Matsubara J. и др. Long-term follow-up results of the iliofemoral venous thrombosis.//J. Cardiovasc. Surg. (Torino). 1976. Т. 17, N 3. С. 234 - 239.

483. Plate G., Einarsson E., Ohlin P. Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis//J. Vasc. Surg. Elsevier, 1984. Т. 1, N 6. С. 867 - 876.

484. Sato S. и др. [Conservative treatment of acute deep vein thrombosis of lower extremities].//Nihon Geka Gakkai Zasshi. 1992. Т. 93, N 9. С. 1052 - 1054.

485. Stiegler H. и др. [Operation, lysis, heparin therapy: 3 equally valid forms of therapy in acute leg-pelvic venous thrombosis].//Vasa. Suppl. 1987. Т. 20. С. 153 - 156.

486. S. и др. The long-term outcome of proximal vein thrombosis during pregnancy is not improved by the addition of surgical thrombectomy to anticoagulant treatment//Eur. J. Vasc. Endovasc. Surg. Elsevier, 1996. Т. 12, N 1. С. 31 - 36.

487. Seager M.J. и др. Editor's Choice-- A Systematic Review of Endovenous Stenting in Chronic Venous Disease Secondary to Iliac Vein Obstruction.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2016. Т. 51, N 1. С. 100 - 120.

488. Eijgenraam P., ten Cate H., ten Cate-Hoek A.J. Venous stenting after deep venous thrombosis and antithrombotic therapy: A systematic review//Rev. Vasc. Med. Elsevier, 2014. Т. 2, N 3. С. 88 - 97.

489. Breen K., Breen K. Role of venous stenting for venous thromboembolism//Hematol. Am. Soc. Hematol. Educ. Progr. Hematology Am Soc Hematol Educ Program, 2020. Т. 2020, N 1. С. 606 - 611.

490. Hage A., Srinivasa R., Abramowitz S. Endovascular Iliocaval Stent Reconstruction for Iliocaval Thrombosis: A Multi-Institutional International Practice Pattern Survey//Ann. Vasc. Surg. Ann Vasc Surg, 2018. Т. 49. С. 64 - 74.

491. Milinis K. и др. Antithrombotic Therapy Following Venous Stenting: International Delphi Consensus.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2018. Т. 55, N 4. С. 537 - 544.

492. Taha M.M.A.H., Busuttil A., Bootun R. A systematic review on the use of deep venous stenting for acute venous thrombosis of the lower limb//Phlebology. SAGE Publications Sage UK: London, England, 2019. Т. 34, N 2. С. 115 - 127.

493. B kgaard N., Broholm R., Just S. Indications for stenting during thrombolysis//Phlebology. SAGE Publications Sage UK: London, England, 2013. Т. 28, N 1_suppl. С. 112 - 116.

494. Meng Q.-Y. и др. Stenting of iliac vein obstruction following catheter-directed thrombolysis in lower extremity deep vein thrombosis.//Chin. Med. J. (Engl). LWW, 2013. Т. 126, N 18. С. 3519 - 3522.

495. Raju S. Treatment of iliac-caval outflow obstruction//Semin. Vasc. Surg. Semin Vasc Surg, 2015. Т. 28, N 1. С. 47 - 53.

496. Razavi M., Jaff M., Miller L. Safety and Effectiveness of Stent Placement for Iliofemoral Venous Outflow Obstruction: Systematic Review and Meta-Analysis//Circ. Cardiovasc. Interv. Circ Cardiovasc Interv, 2015. Т. 8, N 10.

497. Rodrigues L., Bertanha M., El Dib R. Association between deep vein thrombosis and stent patency in symptomatic iliac vein compression syndrome: Systematic review and meta-analysis//J. Vasc. surgery. Venous Lymphat. Disord. J Vasc Surg Venous Lymphat Disord, 2021. Т. 9, N 1. С. 275 - 284.

498. Raju S., Owen S., Neglen P. The clinical impact of iliac venous stents in the management of chronic venous insufficiency.//J. Vasc. Surg. Elsevier, 2002. Т. 35, N 1. С. 8 - 15.

499. May R., Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins.//Angiology. Sage Publications Sage CA: Thousand Oaks, CA, 1957. Т. 8, N 5. С. 419 - 427.

500. Cockett F.B., Thomas M.L. The iliac compression syndrome//Br. J. Surg. Wiley Online Library, 1965. Т. 52, N 10. С. 816 - 821.

501. Ochoa Chaar C., Aurshina A. Endovascular and Open Surgery for Deep Vein Thrombosis//Clin. Chest Med. Clin Chest Med, 2018. Т. 39, N 3. С. 631 - 644.

502. Majeed G.M. и др. A Systematic Review and Meta-Analysis of 12-Month Patency After Intervention for Iliofemoral Obstruction Using Dedicated or Non-Dedicated Venous Stents.//J. Endovasc. Ther. SAGE Publications Sage CA: Los Angeles, CA, 2022. Т. 29, N 3. С. 478 - 492.

503. Garcia R. и др. Present and future options for treatment of infrainguinal deep vein disease.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2018. Т. 6, N 5. С. 664 - 671.

504. DeYoung E., Minocha J. Inferior Vena Cava Filters: Guidelines, Best Practice, and Expanding Indications.//Semin. Intervent. Radiol. Thieme Medical Publishers, 2016. Т. 33, N 2. С. 65 - 70.

505. Арсланбеков М.М., Ефремова О.И., Золотухин И.А. Эмболия в кава-фильтр: критерии, разработанные с использованием модифицированного метода Delphi//Флебология. Общество с ограниченной ответственностью Издательство Медиа Сфера, 2020. Т. 14, N 3. С. 184 - 188.

506. Liu Y. и др. Effect of inferior vena cava filters on pulmonary embolism-related mortality and major complications: a systematic review and meta-analysis of randomized controlled trials.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2021. Т. 9, N 3. С. 792 - 800.e2.

507. Ahmed O. и др. Inferior Vena Cava Filter Evaluation and Management for the Diagnostic Radiologist: A Comprehensive Review Including Inferior Vena Cava Filter-Related Complications and PRESERVE Trial Filters.//Can. Assoc. Radiol. J. Elsevier, 2019. Т. 70, N 4. С. 367 - 382.

508. Gillespie D.L. и др. Predicting the Safety and Effectiveness of Inferior Vena Cava Filters Study: Design of a unique safety and effectiveness study of inferior vena cava filters in clinical practice.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2020. Т. 8, N 2. С. 187 - 194.e1.

509. Kaufman J.A. и др. Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference.//Surg. Obes. Relat. Dis. Springer, 2006. Т. 2, N 2. С. 200 - 212.

510. Mismetti P. и др. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.//JAMA. American Medical Association, 2015. Т. 313, N 16. С. 1627 - 1635.

511. Decousus H. и др. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Pr vention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.//N. Engl. J. Med. Mass Medical Soc, 1998. Т. 338, N 7. С. 409 - 415.

512. White R.H. и др. Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism//Circulation. Am Heart Assoc, 2016. Т. 133, N 21. С. 2018 - 2029.

513. Jaff M.R. и др. Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension//Circulation. Am Heart Assoc, 2011. Т. 123, N 16. С. 1788 - 1830.

514. Золотухин И.А. и др. Оценка обоснованности показаний к имплантации кава-фильтров при венозных тромбоэмболических осложнениях//Флебология. 2021. Т. 15, N 2. С. 80.

515. Norris C.S., Greenfield L.J., Herrmann J.B. Free-floating iliofemoral thrombus. A risk of pulmonary embolism.//Arch. Surg. American Medical Association, 1985. Т. 120, N 7. С. 806 - 808.

516. Streiff M.B. Vena caval filters: a comprehensive review.//Blood. American Society of Hematology Washington, DC, 2000. Т. 95, N 12. С. 3669 - 3677.

517. Zhao H. и др. Comparison of the in vitro clot-capturing efficiencies of commercially available retrievable inferior vena cava filters.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2022. Т. 10, N 2. С. 463 - 468.e2.

518. Порембская О.Я. и др. Легочная эмболия - разрозненные части несобранной мозаики//Флебология. 2021. Т. 15, N 3. С. 188.

519. Caplin D.M. и др. Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism.//J. Vasc. Interv. Radiol. Elsevier, 2011. Т. 22, N 11. С. 1499 - 1506.

520. Radiology A.C. of, Radiology S. of I. ACR-SIR-SPR practice parameter for the performance of inferior vena cava filter placement for the Prevention of Pulmonary Embolism. Fairfax, VA: American College of Radiology/Society of Interventional Radiology, 2016.

521. Ni H., Win L.L.L. Retrievable inferior vena cava filters for venous thromboembolism//Int. Sch. Res. Not. Hindawi, 2013. Т. 2013. С. 1 - 8.

522. Imberti D. и др. Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study.//J. Thromb. Haemost. Wiley Online Library, 2005. Т. 3, N 7. С. 1370 - 1375.

523. Dake M.M.D., Murphy T.T.P.T., Kr mer A.A.H. One-year analysis of the prospective multicenter SENTRY clinical trial: safety and effectiveness of the Novate Sentry Bioconvertible Inferior Vena Cava Filter//J. Vasc. Interv. Radiol. Elsevier, 2018. Т. 29, N 10. С. 1350 - 1361.

524. Le Blanche A.F. и др. The optional VenaTech(TM) Convertible (TM) vena cava filter: experimental study in sheep.//Cardiovasc. Intervent. Radiol. Springer, 2012. Т. 35, N 5. С. 1181 - 1187.

525. Kusuyama T. и др. Patient with a massive idiopathic thrombosis in the inferior vena cava.//Ann. Vasc. Dis. The Editorial Committee of Annals of Vascular Diseases, 2012. Т. 5, N 1. С. 89 - 91.

526. Smith S.J. и др. Vacuum-assisted thrombectomy device (AngioVac) in the management of symptomatic iliocaval thrombosis.//J. Vasc. Interv. Radiol. Elsevier, 2014. Т. 25, N 3. С. 425 - 430.

527. Гаврилов Е.К., Тарасов В.А., Хубулава Г.Г. Опыт диагностики, лечебной тактики и оперативных вмешательств при обструкции нижней полой вены различного генеза.//Флебология. 2020. Т. 14, N 4.

528. Игнатьев И.М., Акчурин Ф.Р., Заночкин А.В. Опыт лечения флотирующих тромбозов в системе нижней полой вены//Флебология. Издательство'Медиа Сфера', 2011. Т. 5, N 4. С. 44 - 51.

529. Кириенко А.И., Андрияшкин В.В., Иванов В.В. Открытые оперативные вмешательства в лечении больных с поздними осложнениями имплантации кава-фильтров//Флебология. Издательство'Медиа Сфера', 2018. Т. 12, N 1. С. 4 - 11.

530. Кириенко А.И., Андрияшкин В.В., Лебедев И.С. Тромбоз супраренального отдела нижней полой вены и правого предсердия при раке желудка//Хирургия. Журнал им. НИ Пирогова. Общество с ограниченной ответственностью Издательство Медиа Сфера, 2014. N 8. С. 81 - 82.

531. D'Ayala M. и др. Factors Associated with Successful Thrombus Extraction with the AngioVac Device: An Institutional Experience.//Ann. Vasc. Surg. Elsevier, 2017. Т. 38. С. 242 - 247.

532. Donaldson C.W. и др. Thrombectomy using suction filtration and veno-venous bypass: single center experience with a novel device.//Catheter. Cardiovasc. Interv. Wiley Online Library, 2015. Т. 86, N 2. С. E81-7.

533. Ray C.E., Prochazka A. The need for anticoagulation following inferior vena cava filter placement: systematic review.//Cardiovasc. Intervent. Radiol. Springer, 2008. Т. 31, N 2. С. 316 - 324.

534. Langham M.R., Hoffman M.J., Greenfield L.J. Effect of anticoagulation on the lysis of filter entrapped thromboembolism in dogs.//J. Surg. Res. Elsevier, 1985. Т. 38, N 4. С. 391 - 399.

535. Ageno W. и др. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH.//J. Thromb. Haemost. Wiley Online Library, 2013. Т. 11, N 8. С. 1597 - 1602.

536. Egermayer P. The effects of heparin and oral anticoagulants on thrombus propagation and prevention of the postphlebitic syndrome: a critical review of the literature.//Prog. Cardiovasc. Dis. Elsevier, 2001. Т. 44, N 1. С. 69 - 80.

537. Gautam G., Sebastian T., Klok F.A. How to Differentiate Recurrent Deep Vein Thrombosis from Postthrombotic Syndrome.//Hamostaseologie. Georg Thieme Verlag KG, 2020. Т. 40, N 3. С. 280 - 291.

538. van Dam L.F. и др. Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis.//Blood. American Society of Hematology, 2020. Т. 135, N 16. С. 1377 - 1385.

539. Kyrle P.A. How I treat recurrent deep-vein thrombosis.//Blood. American Society of Hematology Washington, DC, 2016. Т. 127, N 6. С. 696 - 702.

540. van Dam L.F., Gautam G., Dronkers C.E.A. Safety of using the combination of the Wells rule and D dimer test for excluding acute recurrent ipsilateral deep vein thrombosis//J. Thromb. Haemost. Wiley Online Library, 2020. Т. 18, N 9. С. 2341 - 2348.

541. Hassen S. и др. High percentage of non-diagnostic compression ultrasonography results and the diagnosis of ipsilateral recurrent proximal deep vein thrombosis: a rebuttal.//J. Thromb. Haemost. Wiley Online Library, 2011. Т. 9, N 2. С. 414 - 416; author reply 417-8.

542. Schulman S. How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy.//Blood. American Society of Hematology Washington, DC, 2017. Т. 129, N 25. С. 3285 - 3293.

543. Luk C. и др. Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy.//Am. J. Med. Elsevier, 2001. Т. 111, N 4. С. 270 - 273.

544. Carrier M. и др. Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients.//J. Thromb. Haemost. Wiley Online Library, 2009. Т. 7, N 5. С. 760 - 765.

545. Joseph L. и др. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.//J. Thromb. Haemost. Wiley Online Library, 2014. Т. 12, N 7. С. 1044 - 1053.

546. van Es N. и др. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials//Blood. American Society of Hematology Washington, DC, 2014. Т. 124, N 12. С. 1968 -1975.

547. Чечулова А.В. и др. Особенности кровотечений на фоне антикоагулянтной терапии у пациентов пожилого и старческого возраста с тромбозом глубоких вен.//Флебология. 2021. Т. 15, N 3.

548. Pengo V., Denas G. Optimizing quality care for the oral vitamin K antagonists (VKAs)//Hematology. American Society of Hematology Washington, DC, 2018. Т. 2018, N 1. С. 332 - 338.

549. Palareti G., Cosmi B. Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients.//Thromb. Haemost. Schattauer GmbH, 2009. Т. 102, N 2. С. 268 - 278.

550. Sarode R. и др. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.//Circulation. Am Heart Assoc, 2013. Т. 128, N 11. С. 1234 - 1243.

551. Chai-Adisaksopha C. и др. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis.//Thromb. Haemost. Schattauer GmbH, 2016. Т. 116, N 5. С. 879 - 890.

552. Steiner T. и др. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial.//Lancet. Neurol. Elsevier, 2016. Т. 15, N 6. С. 566 - 573.

553. Pollack C. V и др. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.//N. Engl. J. Med. Mass Medical Soc, 2017. Т. 377, N 5. С. 431 - 441.

554. Chaudhary R. и др. Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis.//JAMA Netw. open. American Medical Association, 2022. Т. 5, N 11. С. e2240145.

555. Piran S. и др. Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis.//Blood Adv. American Society of Hematology Washington, DC, 2019. Т. 3, N 2. С. 158 - 167.

556. Shaw J.R. и др. DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays-a review of the literature//J. Thromb. Haemost. Elsevier, 2023. Т. 21, N 3. С. 433 - 452.

557. Connolly S.J. и др. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.//N. Engl. J. Med. Mass Medical Soc, 2019. Т. 380, N 14. С. 1326 - 1335.

558. Partsch H. Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation.//Vasa. 2001. Т. 30, N 3. С. 195 - 204.

559. Rice L. Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient).//Arch. Intern. Med. American Medical Association, 2004. Т. 164, N 18. С. 1961 - 1964.

560. Martel N., Lee J., Wells P.S. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.//Blood. American Society of Hematology, 2005. Т. 106, N 8. С. 2710 - 2715.

561. Smythe M.A., Koerber J.M., Mattson J.C. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital.//Chest. Elsevier, 2007. Т. 131, N 6. С. 1644 - 1649.

562. Ivascu N.S. и др. Heparin-Induced Thrombocytopenia: A Review for Cardiac Anesthesiologists and Intensivists.//J. Cardiothorac. Vasc. Anesth. Elsevier, 2019. Т. 33, N 2. С. 511 - 520.

563. Warkentin T.E. и др. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.//N. Engl. J. Med. Mass Medical Soc, 1995. Т. 332, N 20. С. 1330 - 1335.

564. Warkentin T.E. и др. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).//Chest. Elsevier, 2008. Т. 133, N 6 Suppl. С. 340S - 380S.

565. Warkentin T.E., Kelton J.G. Temporal aspects of heparin-induced thrombocytopenia.//N. Engl. J. Med. Mass Medical Soc, 2001. Т. 344, N 17. С. 1286 - 1292.

566. Salter B.S. и др. Heparin-Induced Thrombocytopenia: A Comprehensive Clinical Review.//J. Am. Coll. Cardiol. American College of Cardiology Foundation Washington, DC, 2016. Т. 67, N 21. С. 2519 - 2532.

567. Sun X. и др. Heparin-Induced Thrombocytopenia in Contemporary Cardiac Surgical Practice and Experience With a Protocol for Early Identification.//Am. J. Cardiol. Elsevier, 2016. Т. 117, N 2. С. 305 - 309.

568. Cuker A. Management of the multiple phases of heparin-induced thrombocytopenia.//Thromb. Haemost. Schattauer GmbH, 2016. Т. 116, N 5. С. 835 - 842.

569. Warkentin T.E., Kelton J.G. A 14-year study of heparin-induced thrombocytopenia.//Am. J. Med. Elsevier, 1996. Т. 101, N 5. С. 502 - 507.

570. Warkentin T.E. Heparin-induced thrombocytopenia: pathogenesis and management//Br. J. Haematol. Wiley Online Library, 2003. Т. 121, N 4. С. 535 - 555.

571. Cuker A. Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis.//Thromb. Haemost. Schattauer GmbH, 2011. Т. 106, N 6. С. 993 - 994.

572. Greinacher A. и др. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range.//Blood. American Society of Hematology Washington, DC, 2000. Т. 96, N 3. С. 846 - 851.

573. Linkins L., Hu G., Warkentin T.E. Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials.//Res. Pract. Thromb. Haemost. Wiley Online Library, 2018. Т. 2, N 4. С. 678 - 683.

574. Barlow A. и др. Potential Role of Direct Oral Anticoagulants in the Management of Heparin-induced Thrombocytopenia.//Pharmacotherapy. Wiley Online Library, 2019. Т. 39, N 8. С. 837 - 853.

575. Tran P.N., Tran M.-H. Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia//Clin. Appl. Thromb. SAGE Publications Sage CA: Los Angeles, CA, 2018. Т. 24, N 2. С. 201 - 209.

576. Linkins L.A. и др. Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.//J. Thromb. Haemost. Wiley Online Library, 2016. Т. 14, N 6. С. 1206 - 1210.

577. Warkentin T.E., Pai M., Linkins L.-A. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.//Blood. American Society of Hematology Washington, DC, 2017. Т. 130, N 9. С. 1104 - 1113.

578. Jung M. и др. Safety of IVC Filters with Heparin-Induced Thrombocytopenia: A Retrospecive Study//Blood. American Society of Hematology, 2011. Т. 118, N 21. С. 2225 - 2225.

579. Hong A.P. и др. Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia.//Blood. American Society of Hematology Washington, DC, 2003. Т. 101, N 8. С. 3049 - 3051.

580. Warkentin T.E. и др. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia.//Ann. Intern. Med. American College of Physicians, 1997. Т. 127, N 9. С. 804 - 812.

581. Srinivasan A.F. и др. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia.//Arch. Intern. Med. American Medical Association, 2004. Т. 164, N 1. С. 66 - 70.

582. Goel R. и др. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.//Blood. American Society of Hematology Washington, DC, 2015. Т. 125, N 9. С. 1470 - 1476.

583. РОАГ. Венозные осложнения во время беременности и послеродовом периоде. Акушерская тромбоэмболия. Клинические рекомендации [Электронный ресурс]. 2022. URL: https://cr.minzdrav.gov.ru/schema/723_1.

584. АФР. Флебит и тромбофлебит поверхностных сосудов. Клинические рекомендации [Электронный ресурс]. 2021. URL: cr.minzdrav.gov.ru/recomend/668_1.

585. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy.//Obstet. Gynecol. 2018. Т. 132, N 1. С. e1 - e17.

586. RCOG. Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk. RCOG Green-top Guideline No. 37a [Электронный ресурс]. URL: www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a/.

587. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 197: Inherited Thrombophilias in Pregnancy.//Obstet. Gynecol. 2018. Т. 132, N 1. С. e18 - e34.

588. Bates S.M. и др. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.//J. Thromb. Thrombolysis. Springer, 2016. Т. 41, N 1. С. 92 - 128.

589. Middeldorp S. Is thrombophilia testing useful?//Hematol. Am. Soc. Hematol. Educ. Progr. American Society of Hematology Washington, DC, 2011. Т. 2011, N 1. С. 150 - 155.

590. Jacobsen A.F., Skjeldestad F.E., Sandset P.M. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study.//Am. J. Obstet. Gynecol. Elsevier, 2008. Т. 198, N 2. С. 233. e1 - 7.

591. RCOG. Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management. RCOG Green-top Guideline No. 37b [Электронный ресурс]. 2015. URL: www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37b/.

592. Bates S.M. и др. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.//Chest. Elsevier, 2012. Т. 141, N 2 Suppl. С. e691S - e736S.

593. Cohen S.L. и др. Comparison of international societal guidelines for the diagnosis of suspected pulmonary embolism during pregnancy.//Lancet. Haematol. Elsevier, 2020. Т. 7, N 3. С. e247 - e258.

594. Mallick S., Petkova D. Investigating suspected pulmonary embolism during pregnancy.//Respir. Med. Elsevier, 2006. Т. 100, N 10. С. 1682 - 1687.

595. Wan T. и др. Guidance for the diagnosis of pulmonary embolism during pregnancy: Consensus and controversies.//Thromb. Res. Elsevier, 2017. Т. 157. С. 23 - 28.

596. Righini M. и др. Diagnosis of Pulmonary Embolism During Pregnancy: A Multicenter Prospective Management Outcome Study.//Ann. Intern. Med. American College of Physicians, 2018. Т. 169, N 11. С. 766 - 773.

597. van der Pol L.M. и др. Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism.//N. Engl. J. Med. Mass Medical Soc, 2019. Т. 380, N 12. С. 1139 - 1149.

598. Greer I.A., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.//Blood. 2005. Т. 106, N 2. С. 401 - 407.

599. Sagaram D. и др. Heparin-Induced Thrombocytopenia during Obstetric Hospital Admissions.//Am. J. Perinatol. Thieme Medical Publishers, 2018. Т. 35, N 9. С. 898 - 903.

600. To M.S., Hunt B.J., Nelson-Piercy C. A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy.//J. Obstet. Gynaecol. Taylor & Francis, 2008. Т. 28, N 2. С. 222 - 223.

601. McLintock C. и др. Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period.//Aust. N. Z. J. Obstet. Gynaecol. LWW, 2012. Т. 52, N 1. С. 14 - 22.

602. Leung A.N. и др. American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline--Evaluation of Suspected Pulmonary Embolism in Pregnancy.//Radiology. American Thoracic Society, 2012. Т. 262, N 2. С. 635 - 646.

603. Bajc M. и др. EANM guidelines for ventilation/perfusion scintigraphy: Part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography.//Eur. J. Nucl. Med. Mol. Imaging. Springer, 2009. Т. 36, N 8. С. 1356 - 1370.

604. Linnemann B. и др. Diagnosis of pregnancy-associated venous thromboembolism - position paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH).//Vasa. 2016. Т. 45, N 2. С. 87 - 101.

605. Chan W.-S. и др. Venous thromboembolism and antithrombotic therapy in pregnancy.//J. Obstet. Gynaecol. Can. Elsevier, 2014. Т. 36, N 6. С. 527 - 553.

606. Torkzad M.R. и др. Magnetic resonance imaging and ultrasonography in diagnosis of pelvic vein thrombosis during pregnancy.//Thromb. Res. Elsevier, 2010. Т. 126, N 2. С. 107 - 112.

607. Devis P., Knuttinen M.G. Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management.//Cardiovasc. Diagn. Ther. AME Publications, 2017. Т. 7, N Suppl 3. С. S309 - S319.

608. Damodaram M. и др. D-dimers as a screening test for venous thromboembolism in pregnancy: is it of any use?//J. Obstet. Gynaecol. Taylor & Francis, 2009. Т. 29, N 2. С. 101 - 103.

609. Kovac M. и др. The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy.//Eur. J. Obstet. Gynecol. Reprod. Biol. Elsevier, 2010. Т. 148, N 1. С. 27 - 30.

610. Rabe E. и др. Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement.//Phlebology. SAGE Publications Sage UK: London, England, 2018. Т. 33, N 3. С. 163 - 184.

611. Sivolella S., De Biagi M., Brunello G. Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants//Odontology. Odontology, 2015. Т. 103, N 3. С. 258 - 263.

612. Johnston S. An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery//Int. J. Oral Maxillofac. Surg. Int J Oral Maxillofac Surg, 2016. Т. 45, N 5. С. 618 - 630.

613. Mauprivez C., Khonsari R., Razouk O. Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study//Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Oral Surg Oral Med Oral Pathol Oral Radiol, 2016. Т. 122, N 5. С. e146 - e155.

614. Patel J., Woolcombe S., Patel R. Managing direct oral anticoagulants in patients undergoing dentoalveolar surgery//Br. Dent. J. Br Dent J, 2017. Т. 222, N 4. С. 245 - 249.

615. Yagyuu T., Kawakami M., Ueyama Y. Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: A retrospective cohort study//BMJ Open. BMJ Open, 2017. Т. 7, N 8.

616. Miclotte I., Vanhaverbeke M., Agbaje J. Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study//Clin. Oral Investig. Clin Oral Investig, 2017. Т. 21, N 7. С. 2183 - 2188.

617. Zaib A. и др. Local Tranexamic Acid for Preventing Hemorrhage in Anticoagulated Patients Undergoing Dental and Minor Oral Procedures: A Systematic Review and Meta-Analysis//Healthcare. MDPI, 2022. Т. 10, N 12. С. 2523.

618. Kakkos S.K. и др. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2016. Т. 9, N 9. С. CD005258.

619. Ho K.M., Tan J.A. Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients.//Circulation. Am Heart Assoc, 2013. Т. 128, N 9. С. 1003 - 1020.

620. Dong K. и др. Pentasaccharides for the prevention of venous thromboembolism.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2016. Т. 10, N 10. С. CD005134.

621. Sachdeva A., Dalton M., Lees T. Graduated compression stockings for prevention of deep vein thrombosis.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2018. Т. 11, N 11. С. CD001484.

622. Collins R. и др. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.//N. Engl. J. Med. Wolters Kluwer Philadelphia, PA, 1988. Т. 318, N 18. С. 1162 - 1173.

623. Mismetti P. и др. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.//Br. J. Surg. Wiley Online Library, 2001. Т. 88, N 7. С. 913 - 930.

624. Koch A. и др. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.//Br. J. Surg. Wiley Online Library, 1997. Т. 84, N 6. С. 750 - 759.

625. Lederle F.A. и др. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline.//Ann. Intern. Med. American College of Physicians, 2011. Т. 155, N 9. С. 602 - 615.

626. J rgensen L.N., Wille-J rgensen P., Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins.//Br. J. Surg. Wiley Online Library, 1993. Т. 80, N 6. С. 689 - 704.

627. Tafur A., Douketis J. Perioperative management of anticoagulant and antiplatelet therapy.//Heart. BMJ Publishing Group Ltd and British Cardiovascular Society, 2018. Т. 104, N 17. С. 1461 - 1467.

628. Kuo H. и др. Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: A systematic review and meta-analysis.//Clin. Cardiol. Wiley Online Library, 2020. Т. 43, N 5. С. 441 - 449.

629. Douketis J.D. Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach.//Blood. American Society of Hematology Washington, DC, 2011. Т. 117, N 19. С. 5044 - 5049.

630. Jaffer A.K. и др. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.//Am. J. Med. Elsevier, 2010. Т. 123, N 2. С. 141 - 150.

631. Singer D.E. и др. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).//Chest. Elsevier, 2008. Т. 133, N 6 Suppl. С. 546S - 592S.

632. Salem D.N. и др. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).//Chest. Elsevier, 2008. Т. 133, N 6 Suppl. С. 593S - 629S.

633. Siegal D. и др. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.//Circulation. Am Heart Assoc, 2012. Т. 126, N 13. С. 1630 - 1639.

634. Tafur A.J. и др. Predictors of major bleeding in peri-procedural anticoagulation management.//J. Thromb. Haemost. Wiley Online Library, 2012. Т. 10, N 2. С. 261 - 267.

635. Ansell J. и др. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.//Chest. Elsevier, 2004. Т. 126, N 3 Suppl. С. 204S - 233S.

636. Douketis J.D. и др. Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery.//Thromb. Haemost. Schattauer GmbH, 2005. Т. 94, N 3. С. 528 - 531.

637. O'Donnell M.J. и др. Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin.//Ann. Intern. Med. 2007. Т. 146, N 3. С. 184 - 187.

638. Strebel N. и др. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?//Arch. Intern. Med. American Medical Association, 2002. Т. 162, N 13. С. 1451 - 1456.

639. Douketis J., Spyropoulos A., Kaatz S. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation//N. Engl. J. Med. N Engl J Med, 2015. Т. 373, N 9. С. 823 - 833.

640. Dunn A.S., Spyropoulos A.C., Turpie A.G.G. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT).//J. Thromb. Haemost. Wiley Online Library, 2007. Т. 5, N 11. С. 2211 - 2218.

641. Kovacs M.J. и др. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial//BMJ. British Medical Journal Publishing Group, 2021. Т. 373. С. n1205.

642. Douketis J.D. и др. Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline//Chest. Elsevier, 2022. Т. 162, N 5. С. e207 - e243.

643. Beyer-Westendorf J., Gelbricht V., F rster K. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry//Eur. Heart J. Eur Heart J, 2014. Т. 35, N 28. С. 1888 - 1896.

644. Douketis J.D. и др. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.//JAMA Intern. Med. American Medical Association, 2019. Т. 179, N 11. С. 1469 - 1478.

645. Sherwood M.W. и др. Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stro//Circulation. Am Heart Assoc, 2014. Т. 129, N 18. С. 1850 - 1859.

646. Douketis J.D. и др. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.//Thromb. Haemost. Schattauer GmbH, 2015. Т. 113, N 3. С. 625 - 632.

647. Shaw J.R. и др. Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure.//Blood Adv. American Society of Hematology Washington, DC, 2020. Т. 4, N 15. С. 3520 - 3527.

648. Heidbuchel H. и др. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.//Eur. Heart J. Oxford University Press, 2013. Т. 34, N 27. С. 2094 - 2106.

649. Kearon C., Hirsh J. Management of anticoagulation before and after elective surgery.//N. Engl. J. Med. Mass Medical Soc, 1997. Т. 336, N 21. С. 1506 - 1511.

650. White R.H. и др. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.//Ann. Intern. Med. American College of Physicians, 1995. Т. 122, N 1. С. 40 - 42.

651. Larson B.J.G., Zumberg M.S., Kitchens C.S. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.//Chest. Elsevier, 2005. Т. 127, N 3. С. 922 - 927.

652. Jenny J.Y., Pabinger I., Samama C.M. European guidelines on perioperative venous thromboembolism prophylaxis//Eur. J. Anaesthesiol. Lippincott Williams and Wilkins, 2018. Т. 35, N 2. С. 123 - 129.

653. Levy J.H., Tanaka K.A., Dietrich W. Perioperative hemostatic management of patients treated with vitamin K antagonists.//Anesthesiology. The American Society of Anesthesiologists, 2008. Т. 109, N 5. С. 918 - 926.

654. Polania Gutierrez J.J., Rocuts K.R. Perioperative Anticoagulation Management//StatPearls. 2022.

655. Bateman B.T. и др. The risk and outcomes of epidural hematomas after perioperative and obstetric epidural catheterization: a report from the Multicenter Perioperative Outcomes Group Research Consortium.//Anesth. Analg. LWW, 2013. Т. 116, N 6. С. 1380 - 1385.

656. Moen V., Dahlgren N., Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990 - 1999.//Anesthesiology. The American Society of Anesthesiologists, 2004. Т. 101, N 4. С. 950 - 959.

657. Horlocker T.T. и др. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition).//Reg. Anesth. Pain Med. Wolters Kluwer, 2018. Т. 43, N 3. С. 263 - 309.

658. Vandermeulen E.P., Van Aken H., Vermylen J. Anticoagulants and spinal-epidural anesthesia.//Anesth. Analg. LWW, 1994. Т. 79, N 6. С. 1165 - 1177.

659. Liu S.S., Mulroy M.F. Neuraxial anesthesia and analgesia in the presence of standard heparin.//Reg. Anesth. Pain Med. Lippincott Williams & Wilkins Ovid Technologies, 1998. Т. 23, N 6 Suppl 2. С. 157 - 163.

660. Chaney M.A. Intrathecal and epidural anesthesia and analgesia for cardiac surgery.//Anesth. Analg. LWW, 2006. Т. 102, N 1. С. 45 - 64.

661. Davis J.J. и др. Three-times-daily subcutaneous unfractionated heparin and neuraxial anesthesia: a retrospective review of 928 cases.//Reg. Anesth. Pain Med. BMJ Publishing Group Ltd, 2012. Т. 37, N 6. С. 623 - 626.

662. Pace M., Koury K., Gulur P. Epidurals in patients receiving thromboprophylaxis with unfractionated heparin three times a day: the value of activated partial thromboplastin time testing.//Anesth. Analg. LWW, 2014. Т. 119, N 5. С. 1215 - 1218.

663. Weitz J.I. Low-molecular-weight heparins.//N. Engl. J. Med. Mass Medical Soc, 1997. Т. 337, N 10. С. 688 - 698.

664. Tetri S. и др. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.//Thromb. Res. Elsevier, 2008. Т. 123, N 2. С. 206 - 212.

665. Singelyn F.J. и др. The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study.//Anesth. Analg. LWW, 2007. Т. 105, N 6. С. 1540 - 1547, table of contents.

666. Kietaibl S. и др. Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines.//Eur. J. Anaesthesiol. LWW, 2022. Т. 39, N 2. С. 100 - 132.

667. Greenblatt D.J. Elimination half-life of drugs: value and limitations.//Annu. Rev. Med. Annual Reviews 4139 El Camino Way, PO Box 10139, Palo Alto, CA 94303-0139, USA, 1985. Т. 36, N 1. С. 421 - 427.

668. Narouze S. и др. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition): Guidelines From the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Thera//Reg. Anesth. Pain Med. BMJ Publishing Group Ltd, 2018. Т. 43, N 3. С. 225 - 262.

669. Baron T.H., Kamath P.S., McBane R.D. Management of antithrombotic therapy in patients undergoing invasive procedures.//N. Engl. J. Med. Mass Medical Soc, 2013. Т. 368, N 22. С. 2113 - 2124.

670. Liew A., Douketis J. Perioperative management of patients who are receiving a novel oral anticoagulant.//Intern. Emerg. Med. Springer, 2013. Т. 8, N 6. С. 477 - 484.

671. Prandoni P. и др. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.//Blood. American Society of Hematology Washington, DC, 2002. Т. 100, N 10. С. 3484 - 3488.

672. Sobieraj D.M. и др. Anticoagulation for the Treatment of Cancer-Associated Thrombosis: A Systematic Review and Network Meta-Analysis of Randomized Trials.//Clin. Appl. Thromb. Hemost. SAGE Publications Sage CA: Los Angeles, CA, 2018. Т. 24, N 9_suppl. С. 182S - 187S.

673. Лобастов К.В., Счастливцев И.В. Актуальный статус прямых оральных антикоагулянтов при лечении венозных тромбоэмболических осложнений у онкологических больных//Рациональная фармакотерапия в кардиологии. Общество с ограниченной ответственностью "Столичная издательская компания", 2020. Т. 16, N 2. С. 286 - 295.

674. Francis C.W. и др. Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.//J. Thromb. Haemost. Wiley Online Library, 2015. Т. 13, N 6. С. 1028 - 1035.

675. Jara-Palomares L. и др. Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study.//Thromb. Res. Elsevier, 2017. Т. 157. С. 90 - 96.

676. Kirkilesis G.I., Kakkos S.K., Tsolakis I.A. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.//Eur. J. Vasc. Endovasc. Surg. Elsevier, 2019. Т. 57, N 5. С. 685 - 701.

677. Lee A.Y.Y. и др. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.//N. Engl. J. Med. Mass Medical Soc, 2003. Т. 349, N 2. С. 146 - 153.

678. Кательницкая О.В. и др. Особенности антикоагулянтной терапии венозных тромбоэмболических осложнений у пациентов со злокачественными новообразованиями//Флебология. 2020. Т. 14, N 2.

679. Young A.M. и др. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).//J. Clin. Oncol. 2018. Т. 36, N 20. С. 2017 - 2023.

680. McBane R.D. и др. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.//J. Thromb. Haemost. Wiley Online Library, 2020. Т. 18, N 2. С. 411 - 421.

681. Agnelli G. и др. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.//N. Engl. J. Med. 2020. Т. 382, N 17. С. 1599 - 1607.

682. Raskob G.E. и др. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.//N. Engl. J. Med. Mass Medical Soc, 2018. Т. 378, N 7. С. 615 - 624.

683. Giustozzi M. и др. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.//Thromb. Haemost. Georg Thieme Verlag KG, 2020. Т. 120, N 7. С. 1128 - 1136.

684. Riaz I. Bin и др. Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis.//Mayo Clin. Proc. Elsevier, 2022. Т. 97, N 2. С. 308 - 324.

685. Dong S. и др. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.//Ann. Pharmacother. SAGE Publications Sage CA: Los Angeles, CA, 2021. Т. 55, N 4. С. 430 - 439.

686. Houghton D.E. и др. Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism//Mayo Clin. Proc. Elsevier, 2021. Т. 96, N 11. С. 2793 - 2805.

687. Kearon C., Akl E.A., Comerota A.J. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines//Chest. American College of Chest Physicians, 2012. Т. 141, N 2 SUPPL. С. e419S - e496S.

688. ICM-VTE General Delegates. Recommendations from the ICM-VTE: General//J. Bone Jt. Surg. Lippincott Williams and Wilkins Ltd., 2022. Т. 104, N Suppl 1. С. 4 - 162.

689. Song K. и др. The preoperative incidence of deep vein thrombosis (DVT) and its correlation with postoperative DVT in patients undergoing elective surgery for femoral neck fractures.//Arch. Orthop. Trauma Surg. Springer, 2016. Т. 136, N 10. С. 1459 - 1464.

690. Zhang B.-F. и др. Deep vein thrombosis in bilateral lower extremities after hip fracture: a retrospective study of 463 patients.//Clin. Interv. Aging. Dove Press, 2018. Т. 13. С. 681 - 689.

691. Luksameearunothai K. и др. Usefulness of clinical predictors for preoperative screening of deep vein thrombosis in hip fractures.//BMC Musculoskelet. Disord. Springer, 2017. Т. 18, N 1. С. 208.

692. Pan Y. и др. [A single-center retrospective study on the intraluminal implantation of inferior vena cava filter for the lower extremity trauma patients with deep venous thrombosis].//Zhonghua Wai Ke Za Zhi. 2014. Т. 52, N 4. С. 254 - 257.

693. Shao M. и др. [Application of inferior vena cava filters in prevention of peri-operative pulmonary embolism in patients with bone fracture combined with deep venous thrombosis: a report of 572 cases].//Zhonghua Wai Ke Za Zhi. 2012. Т. 50, N 5. С. 418 - 421.

694. Асамов Р.Э. и др. Бессимптомные флеботромбозы и наследственная тромбофилия у больных со скелетной травмой//Ангиология и сосудистая хирургия. Российское общество ангиологов и сосудистых хирургов, 2008. Т. 14, N 3. С. 73 - 78.

695. Власов С.В. и др. Тромбоэмболические осложнения при лечении проксимальных переломов бедренной кости//Политравма. Благотворительный фонд "Центра охраны здоровья шахтеров", 2012. N 3. С. 23 - 28.

696. Алабут А.В. Тактика активной профилактики тромбоэмболических осложнений при эндопротезировании крупных суставов//Медицинский вестник Северного Кавказа. Федеральное государственное бюджетное образовательное учреждение высшего..., 2011. Т. 21, N 1. С. 49 - 51.

697. Sun M.-C., Li M.-S. Intervention for diagnosis of deep vein thrombosis in acute stroke patients: a hospital-based study.//PLoS One. Public Library of Science San Francisco, USA, 2014. Т. 9, N 12. С. e114094.

698. Khan M.T. и др. Deep Vein Thrombosis in Acute Stroke - A Systemic Review of the Literature.//Cureus. Cureus Inc., 2017. Т. 9, N 12. С. e1982.

699. Hughes S. и др. Anticoagulation in chronic kidney disease patients-the practical aspects.//Clin. Kidney J. Oxford University Press, 2014. Т. 7, N 5. С. 442 - 449.

700. Woodruff S., Feug re G., Abreu P. A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment//J. Thromb. Thrombolysis. Springer, 2016. Т. 42, N 4. С. 494 - 504.

701. Aursulesei V., Costache I.I. Anticoagulation in chronic kidney disease: from guidelines to clinical practice.//Clin. Cardiol. Wiley Online Library, 2019. Т. 42, N 8. С. 774 - 782.

702. Martin K.A. и др. Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation.//J. Thromb. Haemost. Wiley Online Library, 2021. Т. 19, N 8. С. 1874 - 1882.

703. Katel A. и др. Efficacy and Safety of Direct Oral Anticoagulants in Venous Thromboembolism Compared to Traditional Anticoagulants in Morbidly Obese Patients: A Systematic Review and Meta-Analysis.//Cureus. Cureus, 2021. Т. 13, N 4. С. e14572.

704. Ihaddadene R., Carrier M. The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety.//Expert Opin. Drug Saf. Taylor & Francis, 2016. Т. 15, N 1. С. 65 - 74.

705. Wilson S.J.-A. и др. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular- weight heparin for the treatment of venous thromboembolism.//Haemostasis. Karger Publishers, 2001. Т. 31, N 1. С. 42 - 48.

706. Sanderink G. и др. The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers.//Clin. Pharmacol. Ther. Wiley Online Library, 2002. Т. 72, N 3. С. 308 - 318.

707. Al-Yaseen E. и др. The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients//J. Thromb. Haemost. Wiley Online Library, 2005. Т. 3, N 1. С. 100 - 102.

708. Bazinet A. и др. Dosage of enoxaparin among obese and renal impairment patients//Thromb. Res. Elsevier, 2005. Т. 116, N 1. С. 41 - 50.

709. Imberti D. и др. Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study)//Obes. Surg. Springer, 2014. Т. 24, N 2. С. 284 - 291.

710. Davidson B.L. и др. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.//J. Thromb. Haemost. Wiley Online Library, 2007. Т. 5, N 6. С. 1191 - 1194.

711. Margaglione M. и др. Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study.//Blood Transfus. SIMTI Servizi, 2020. Т. 18, N 6. С. 486 - 495.

712. Kearon C. и др. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.//Blood. American Society of Hematology Washington, DC, 2008. Т. 112, N 12. С. 4432 - 4436.

713. Elsebaie M.A.T. и др. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta analysis//J. Thromb. Haemost. Wiley Online Library, 2019. Т. 17, N 4. С. 645 - 656.

714. Cohen H. и др. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.//Lancet. Haematol. Elsevier, 2016. Т. 3, N 9. С. e426-36.

715. Goldhaber S.Z. и др. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER(R), RE-COVERTM II, and RE-MEDYTM.//Vasc. Med. SAGE Publications Sage UK: London, England, 2016. Т. 21, N 6. С. 506 - 514.

716. Ginsberg J.S. и др. Antiphospholipid antibodies and venous thromboembolism.//Blood. 1995. Т. 86, N 10. С. 3685 - 3691.

717. Chaturvedi S., McCrae K.R. Diagnosis and management of the antiphospholipid syndrome//Blood Rev. Elsevier, 2017. Т. 31, N 6. С. 406 - 417.

718. Garcia D., Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome.//N. Engl. J. Med. Mass Medical Soc, 2018. Т. 378, N 21. С. 2010 - 2021.

719. Joffe H. V и др. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.//Circulation. Am Heart Assoc, 2004. Т. 110, N 12. С. 1605 - 1611.

720. van den Houten M.M.L. и др. Treatment of upper-extremity outflow thrombosis.//Phlebology. SAGE Publications Sage UK: London, England, 2016. Т. 31, N 1 Suppl. С. 28 - 33.

721. Persson L.M. и др. Hemodynamic and morphologic evaluation of sequelae of primary upper extremity deep venous thromboses treated with anticoagulation.//J. Vasc. Surg. Elsevier, 2006. Т. 43, N 6. С. 1230 - 1235; discussion 1235.

722. Illig K.A., Doyle A.J. A comprehensive review of Paget-Schroetter syndrome.//J. Vasc. Surg. Elsevier, 2010. Т. 51, N 6. С. 1538 - 1547.

723. Hughes E.S.R. Venous obstruction in the upper extremity.//Br. J. Surg. Wiley Online Library, 1948. Т. 36, N 142. С. 155 - 163.

724. Sanders R.J., Hammond S.L., Rao N.M. Diagnosis of thoracic outlet syndrome.//J. Vasc. Surg. Elsevier, 2007. Т. 46, N 3. С. 601 - 604.

725. Freischlag J., Orion K. Understanding thoracic outlet syndrome.//Scientifica (Cairo). Hindawi, 2014. Т. 2014. С. 248163.

726. McCleery R.S. и др. Subclavius and anterior scalene muscle compression as a cause of intermittent obstruction of the subclavian vein//Ann. Surg. Lippincott, Williams, and Wilkins, 1951. Т. 133, N 5. С. 588 - 602.

727. Thiyagarajah K. и др. Post-thrombotic syndrome and recurrent thromboembolism in patients with upper extremity deep vein thrombosis: A systematic review and meta-analysis.//Thromb. Res. Elsevier, 2019. Т. 174. С. 34 - 39.

728. Kucher N. Clinical practice. Deep-vein thrombosis of the upper extremities.//N. Engl. J. Med. Mass Medical Soc, 2011. Т. 364, N 9. С. 861 - 869.

729. Sartori M. и др. D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis.//Thromb. Res. Elsevier, 2015. Т. 135, N 4. С. 673 - 678.

730. Kraaijpoel N. и др. The diagnostic management of upper extremity deep vein thrombosis: A review of the literature.//Thromb. Res. Elsevier, 2017. Т. 156. С. 54 - 59.

731. Hans S.S., Shepard A.D., Weaver M.R. Endovascular and open vascular reconstruction: a practical approach. CRC Press, 2017.

732. Mustafa B.O. и др. Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review.//Arch. Intern. Med. American Medical Association, 2002. Т. 162, N 4. С. 401 - 404.

733. Povlsen S., Povlsen B. Diagnosing Thoracic Outlet Syndrome: Current Approaches and Future Directions.//Diagnostics (Basel, Switzerland). Multidisciplinary Digital Publishing Institute, 2018. Т. 8, N 1. С. 21.

734. Sidawy A.P., Perler B.A. Rutherford's vascular surgery and endovascular therapy, E-Book. Elsevier Health Sciences, 2018.

735. Montiel F.S. и др. Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis.//Thromb. J. BioMed Central, 2017. Т. 15, N 1. С. 26.

736. Schastlivtsev I. и др. Rivaroxaban in the treatment of upper extremity deep vein thrombosis: A single-center experience and review of the literature.//Thromb. Res. Elsevier, 2019. Т. 181. С. 24 - 28.

737. Porfidia A. и др. Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience.//J. Thromb. Thrombolysis. Springer, 2020. Т. 50, N 2. С. 355 - 360.

738. Houghton D.E. и др. Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban.//Am. J. Hematol. Wiley Online Library, 2020. Т. 95, N 7. С. 817 - 823.

739. Lugo J. и др. Acute Paget-Schroetter syndrome: does the first rib routinely need to be removed after thrombolysis?//Ann. Vasc. Surg. Elsevier, 2015. Т. 29, N 6. С. 1073 - 1077.

740. Molina J.E., Hunter D.W., Dietz C.A. Paget-Schroetter syndrome treated with thrombolytics and immediate surgery.//J. Vasc. Surg. Elsevier, 2007. Т. 45, N 2. С. 328 - 334.

741. Stone D.H. и др. Aggressive treatment of idiopathic axillo-subclavian vein thrombosis provides excellent long-term function.//J. Vasc. Surg. Elsevier, 2010. Т. 52, N 1. С. 127 - 131.

742. Karaolanis G. и др. A systematic review and meta-analysis for the management of Paget-Schroetter syndrome.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2021. Т. 9, N 3. С. 801 - 810.e5.

743. Meltzer A.J., Schneider D.B. Surgical techniques: Operative decompression using the infraclavicular approach for VTOS//Thoracic Outlet Syndrome. Springer, 2013. С. 429 - 432.

744. Saber W. и др. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies.//J. Thromb. Haemost. Wiley Online Library, 2011. Т. 9, N 2. С. 312 - 319.

745. Farge D. и др. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.//J. Thromb. Haemost. Wiley Online Library, 2013. Т. 11, N 1. С. 56 - 70.

746. Barco S. и др. Anticoagulants for the prevention and treatment of catheter-related thrombosis in adults and children on parenteral nutrition: a systematic review and critical appraisal.//Blood Transfus. SIMTI Servizi, 2017. Т. 15, N 4. С. 369 - 377.

747. Rajasekhar A., Streiff M.B. How I treat central venous access device-related upper extremity deep vein thrombosis.//Blood. American Society of Hematology Washington, DC, 2017. Т. 129, N 20. С. 2727 - 2736.

748. Baumann Kreuziger L., Jaffray J., Carrier M. Epidemiology, diagnosis, prevention and treatment of catheter-related thrombosis in children and adults//Thromb. Res. Elsevier, 2017. Т. 157. С. 64 - 71.

749. Partsch H., Bl ttler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin.//J. Vasc. Surg. Elsevier, 2000. Т. 32, N 5. С. 861 - 869.

750. Roumen-Klappe E.M. и др. Multilayer compression bandaging in the acute phase of deep-vein thrombosis has no effect on the development of the post-thrombotic syndrome.//J. Thromb. Thrombolysis. Springer, 2009. Т. 27, N 4. С. 400 - 405.

751. Bl ttler W., Partsch H. Leg compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis.//Int. Angiol. Turin, Italy: Minerva Medica, [1982-, 2003. Т. 22, N 4. С. 393 - 400.

752. Kahn S.R. и др. Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial.//Thromb. Haemost. Schattauer GmbH, 2014. Т. 112, N 6. С. 1137 - 1141.

753. Amin E.E. и др. Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis//Blood. American Society of Hematology Washington, DC, 2018. Т. 132, N 21. С. 2298 - 2304.

754. Arpaia G. и др. Efficacy of elastic compression stockings used early or after resolution of the edema on recanalization after deep venous thrombosis: the COM.PRE Trial.//Blood Coagul. Fibrinolysis. LWW, 2007. Т. 18, N 2. С. 131 - 137.

755. Brandjes D.P. и др. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis.//Lancet (London, England). Elsevier, 1997. Т. 349, N 9054. С. 759 - 762.

756. Prandoni P. и др. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial.//Ann. Intern. Med. American College of Physicians, 2004. Т. 141, N 4. С. 249 - 256.

757. Prandoni P. и др. Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial.//Blood. American Society of Hematology Washington, DC, 2012. Т. 119, N 6. С. 1561 - 1565.

758. Tie H.-T. и др. Compression Therapy in the Prevention of Postthrombotic Syndrome: A Systematic Review and Meta-Analysis.//Medicine (Baltimore). Wolters Kluwer Health, 2015. Т. 94, N 31. С. e1318.

759. Partsch H., Kaulich M., Mayer W. Immediate mobilisation in acute vein thrombosis reduces post-thrombotic syndrome.//Int. Angiol. Edizioni Minerva Medica, 2004. Т. 23, N 3. С. 206 - 212.

760. Aschwanden M. и др. Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial.//J. Vasc. Surg. Elsevier, 2008. Т. 47, N 5. С. 1015 - 1021.

761. Mol G.C. и др. One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial.//BMJ. British Medical Journal Publishing Group, 2016. Т. 353. С. i2691.

762. Ten Cate-Hoek A.J. и др. Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial.//Lancet. Haematol. Elsevier, 2018. Т. 5, N 1. С. e25 - e33.

763. Hillegass E. и др. Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism: Evidence-Based Clinical Practice Guideline.//Phys. Ther. Oxford University Press, 2016. Т. 96, N 2. С. 143 - 166.

764. Rocha A.T. и др. Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.//Vasc. Health Risk Manag. Dove Press, 2007. Т. 3, N 4. С. 533 - 553.

765. Excellence N.I. for H. and C. Falls in older people: assessing risk and prevention. NICE, 2013.

766. Wells P.S. и др. Value of assessment of pretest probability of deep-vein thrombosis in clinical management.//Lancet (London, England). Elsevier, 1997. Т. 350, N 9094. С. 1795 - 1798.

767. Kwon O.-Y. и др. Effects of ankle exercise combined with deep breathing on blood flow velocity in the femoral vein.//Aust. J. Physiother. Elsevier, 2003. Т. 49, N 4. С. 253 - 258.

768. Motykie G.D. и др. Risk factor assessment in the management of patients with suspected deep venous thrombosis.//Int. Angiol. Edizioni Minerva Medica, 2000. Т. 19, N 1. С. 47 - 51.

769. Aissaoui N. и др. A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both.//Int. J. Cardiol. Elsevier, 2009. Т. 137, N 1. С. 37 - 41.

770. Kahn S.R., Shrier I., Kearon C. Physical activity in patients with deep venous thrombosis: a systematic review.//Thromb. Res. Elsevier, 2008. Т. 122, N 6. С. 763 - 773.

771. Dupras D., Bluhm J., Felty C. Institute for Clinical Systems Improvement. Venous Thromboembolism Diagnosis and Treatment. 2013.

772. Pieracci F.M. и др. Use of long-term anticoagulation is associated with traumatic intracranial hemorrhage and subsequent mortality in elderly patients hospitalized after falls: analysis of the New York State Administrative Database.//J. Trauma. LWW, 2007. Т. 63, N 3. С. 519 - 524.

773. Inui T.S. и др. Mortality after ground-level fall in the elderly patient taking oral anticoagulation for atrial fibrillation/flutter: a long-term analysis of risk versus benefit.//J. Trauma Acute Care Surg. LWW, 2014. Т. 76, N 3. С. 642 - 649; discussion 649-50.

774. Garvin R., Howard E. Are major bleeding events from falls more likely in patients on warfarin?//J. Fam. Pract. Family Physicians Inquiries Network, 2006. Т. 55, N 2. С. 159 - 160; discussion 159.

775. Garwood C.L., Corbett T.L. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.//Ann. Pharmacother. SAGE Publications Sage CA: Los Angeles, CA, 2008. Т. 42, N 4. С. 523 - 532.

776. Feinberg W.M., Blackshear J.L., Laupacis A. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications//Arch. Intern. Med. American Medical Association, 1995. Т. 155, N 5. С. 469 - 473.

777. Noack F. и др. Feasibility and safety of rehabilitation after venous thromboembolism.//Vasc. Health Risk Manag. Dove Press, 2015. Т. 11. С. 397 - 401.

778. Amoury M. и др. Prognosis of patients with pulmonary embolism after rehabilitation//Vasc. Health Risk Manag. Dove Press, 2018. Т. Volume 14. С. 183 - 187.

779. Blackwell D.L., Lucas J.W., Clarke T.C. Summary health statistics for U.S. adults: national health interview survey, 2012.//Vital Health Stat. 10. 2014. N 260. С. 1 - 161.

780. Stevens J.A. Falls among older adults--risk factors and prevention strategies.//J. Safety Res. 2005. Т. 36, N 4. С. 409 - 411.

781. АТОР. Профилактика венозных тромбоэмболических осложнений в травматологии и ортопедии. Российские клинические рекомендации.//Травматология и ортопедия России. 2012. Т. 63, N 1. С. 3 - 24.

782. Ахтямов И.Ф., Зиатдинов Б.Г., Кильметов Т.А. Эффективность электронейростимуляции как метода профилактики тромбоэмболических осложнений при эндопротезировании тазобедренного сустава. 2017. Т. 8, N 109. С. 29 - 35.

783. Gavish I., Brenner B. Air travel and the risk of thromboembolism.//Intern. Emerg. Med. Springer, 2011. Т. 6, N 2. С. 113 - 116.

784. Kuipers S. и др. The risk of venous thrombosis after air travel: contribution of clinical risk factors.//Br. J. Haematol. 2014. Т. 165, N 3. С. 412 - 413.

785. Belcaro G. и др. Prevention of Venous Thrombosis with Elastic Stockings During Long-Haul Flights: The LONFLIT 5 JAP Study//Clin. Appl. Thromb. Sage Publications Sage CA: Thousand Oaks, CA, 2003. Т. 9, N 3. С. 197 - 201.

786. Belcaro G. и др. Venous Thromboembolism from Air Travel//Angiology. Sage Publications Sage CA: Thousand Oaks, CA, 2001. Т. 52, N 6. С. 369 - 374.

787. Clark S.L., Onida S., Davies A. Long-haul travel and venous thrombosis: What is the evidence?//Phlebol. J. Venous Dis. SAGE Publications Sage UK: London, England, 2018. Т. 33, N 5. С. 295 - 297.

788. Toff W.D., Sugerman H., Ekl f B.G. Venous thrombosis related to air travel--reply.//JAMA. American Medical Association, 2013. Т. 309, N 13. С. 1347.

789. Marques M.A. и др. Venous thromboembolism prophylaxis on flights//J. Vasc. Bras. SciELO Brasil, 2018. Т. 17. С. 215 - 219.

790. Alikhan R. и др. Prevention of venous thromboembolism in medical patients with enoxaparin//Blood Coagul. Fibrinolysis. LWW, 2003. Т. 14, N 4. С. 341 - 346.

791. Cohen A.T. и др. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial//BMJ. British Medical Journal Publishing Group, 2006. Т. 332, N 7537. С. 325 - 329.

792. Cohen A.T. и др. Thromboprophylaxis with dalteparin in medical patients: which patients benefit?//Vasc. Med. Sage Publications Sage UK: London, England, 2007. Т. 12, N 2. С. 123 - 127.

793. Salmaggi A. и др. Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review.//J. Neurooncol. Springer, 2013. Т. 113, N 2. С. 293 - 303.

794. Einstein M.H., Pritts E.A., Hartenbach E.M. Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review.//Gynecol. Oncol. Elsevier, 2007. Т. 105, N 3. С. 813 - 819.

795. Eppsteiner R.W. и др. Mechanical compression versus subcutaneous heparin therapy in postoperative and posttrauma patients: a systematic review and meta-analysis.//World J. Surg. Springer, 2010. Т. 34, N 1. С. 10 - 19.

796. Leonardi M.J., McGory M.L., Ko C.Y. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality.//Ann. Surg. Oncol. Springer, 2007. Т. 14, N 2. С. 929 - 936.

797. Akl E.A. и др. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2014. N 6. С. CD009447.

798. Kakkar V. V и др. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study.//J. Thromb. Haemost. Wiley Online Library, 2010. Т. 8, N 6. С. 1223 - 1229.

799. Kakkar A.K. и др. Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial.//Ann. Surg. LWW, 2014. Т. 259, N 6. С. 1073 - 1079.

800. Vedovati M.C. и др. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer.//Ann. Surg. LWW, 2014. Т. 259, N 4. С. 665 - 669.

801. Auer R. и др. The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease-free survival following surgical resection of colon cancer: a pilot randomized controlled trial.//Blood Coagul. Fibrinolysis. LWW, 2011. Т. 22, N 8. С. 760 - 762.

802. Akl E.A. и др. Extended perioperative thromboprophylaxis in patients with cancer. A systematic review.//Thromb. Haemost. Schattauer GmbH, 2008. Т. 100, N 6. С. 1176 - 1180.

803. Fagarasanu A. и др. Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis.//Ann. Surg. Oncol. Springer, 2016. Т. 23, N 5. С. 1422 - 1430.

804. Guo Q. и др. Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis.//Ann. Surg. LWW, 2017. Т. 265, N 6. С. 1087 - 1093.

805. Rasmussen M.S., J rgensen L.N., Wille-J rgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2009. N 1. С. CD004318.

806. Felder S. и др. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2019. Т. 8, N 8. С. CD004318.

807. Carrier M. и др. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.//Am. J. Med. Elsevier, 2014. Т. 127, N 1. С. 82-6. e1.

808. Agnelli G. и др. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.//Lancet. Oncol. Elsevier, 2009. Т. 10, N 10. С. 943 - 949.

809. Khorana A.A. и др. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.//N. Engl. J. Med. Mass Medical Soc, 2019. Т. 380, N 8. С. 720 - 728.

810. Whitlock R.P. и др. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.//Chest. Elsevier, 2012. Т. 141, N 2 Suppl. С. e576S - e600S.

811. ASA. Arthroplasty Society of Australia guidelines for VTE prophylaxis for hip and knee arthroplasty: Australian Orthopaedic Association. 2018.

812. National Guideline Centre. Venous thromboembolism in over 16s: Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism//National Institute for Health and Care excellence. 2018. Т. 2, N March.

813. Balk E.M. и др. Venous thromboembolism prophylaxis in major orthopedic surgery: systematic review update. 2018.

814. Schulman S. и др. Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing: Observations on NICE Guideline [NG158].//Thromb. Haemost. Georg Thieme Verlag KG, 2020. Т. 120, N 8. С. 1143 - 1146.

815. Forster R., Stewart M. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2016. Т. 3, N 3. С. CD004179.

816. Falck-Ytter Y. и др. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.//Chest. Elsevier, 2012. Т. 141, N 2 Suppl. С. e278S - e325S.

817. An V.V.G.G. и др. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.//J. Arthroplasty. Churchill Livingstone Inc., 2016. Т. 31, N 11. С. 2608 - 2616.

818. Любимов Е.А. и др. Опыт использования ацетилсалициловой кислоты в комплексной профилактике венозных тромбоэмболических осложнений после артропластики коленного сустава.//Флебология. 2020. Т. 14, N 3.

819. Касимова А.Р. и др. Анализ амбулаторного этапа фармакологической тромбопрофилактики у пациентов после эндопротезирования коленного сустава.//Флебология. 2020. Т. 14, N 3.

820. Pedersen A.B. и др. Venous thromboembolism in patients having knee replacement and receiving thromboprophylaxis: a Danish population-based follow-up study.//J. Bone Joint Surg. Am. LWW, 2011. Т. 93, N 14. С. 1281 - 1287.

821. Guijarro R. и др. Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database.//Thromb. Haemost. Thromb Haemost, 2011. Т. 105, N 4. С. 610 - 615.

822. Raphael I.J. и др. Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty?//Clin. Orthop. Relat. Res. Springer, 2014. Т. 472, N 2. С. 482 - 488.

823. Anderson D.R. и др. Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty//Ann. Intern. Med. Ann Intern Med, 2013. Т. 158, N 11. С. 800.

824. Касимова А.Р.Р., Божкова С.А., Тихилов Р.М. Влияние фармакологической тромбопрофилактики, турникета и дренирования на геморрагические осложнения в ранние сроки после эндопротезирования коленного сустава: предварительные результаты//Травматология и ортопедия России. Федеральное государственное бюджетное учреждение "Российский ордена..., 2019. Т. 25, N 3. С. 70 - 80.

825. Касимова А.Р., Божкова С. Применение различных групп лекарственных средств для фармакологической тромбопрофилактики после больших ортопедических операций в клинической практике//Флебология. 2018. Т. 12, N 4. С. 306 - 313.

826. Sarmiento A., Goswami A. Thromboembolic disease prophylaxis in total hip arthroplasty.//Clin. Orthop. Relat. Res. LWW, 2005. Т. 436, N 436. С. 138 - 143.

827. Di Nisio M., van Es N., B ller H.R. Deep vein thrombosis and pulmonary embolism.//Lancet (London, England). Elsevier, 2016. Т. 388, N 10063. С. 3060 - 3073.

828. Huang H.F.H.-F., Tian J.L.J.-L., Sun L. The effect of anticoagulants on venous thrombosis prevention after knee arthroscopy: a systematic review. 2019. Т. 43, N 10. С. 2303 - 2308.

829. Salzler M.J. и др. Complications after arthroscopic knee surgery.//Am. J. Sports Med. SAGE Publications Sage CA: Los Angeles, CA, 2014. Т. 42, N 2. С. 292 - 296.

830. Graham W.C., Flanigan D.C. Venous thromboembolism following arthroscopic knee surgery: a current concepts review of incidence, prophylaxis, and preoperative risk assessment.//Sports Med. Springer, 2014. Т. 44, N 3. С. 331 - 343.

831. Zheng G. и др. No effectiveness of anticoagulants for thromboprophylaxis after non-major knee arthroscopy: a systemic review and meta-analysis of randomized controlled trials.//J. Thromb. Thrombolysis. 2018. Т. 45, N 4. С. 562 - 570.

832. Jameson S.S. и др. Venous thromboembolic events following foot and ankle surgery in the English National Health Service.//J. Bone Joint Surg. Br. The British Editorial Society of Bone and Joint Surgery, 2011. Т. 93, N 4. С. 490 - 497.

833. Calder J.D.F. и др. Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery.//Knee Surg. Sports Traumatol. Arthrosc. Springer, 2016. Т. 24, N 4. С. 1409 - 1420.

834. Weisman M.H.S. и др. Venous Thromboembolic Prophylaxis in Foot and Ankle Surgery: A Review of Current Literature and Practice.//Foot Ankle Spec. SAGE Publications Sage CA: Los Angeles, CA, 2017. Т. 10, N 4. С. 343 - 351.

835. Bikdeli B., Chatterjee S., Desai N.R. Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis//J. Am. Coll. Cardiol. Elsevier USA, 2017. Т. 70, N 13. С. 1587 - 1597.

836. Felcher A.H. и др. Incidence and risk factors for venous thromboembolic disease in podiatric surgery.//Chest. Elsevier, 2009. Т. 135, N 4. С. 917 - 922.

837. Jameson S.S. и др. Venous thromboembolic events are rare after shoulder surgery: analysis of a national database.//J. shoulder Elb. Surg. Elsevier, 2011. Т. 20, N 5. С. 764 - 770.

838. Ojike N.I. и др. Venous thromboembolism in shoulder surgery: a systematic review.//Acta Orthop. Belg. 2011. Т. 77, N 3. С. 281 - 289.

839. Sager B. и др. Timing and Risk Factors for Venous Thromboembolism After Rotator Cuff Repair in the 30-Day Perioperative Period.//Arthroscopy. Elsevier, 2019. Т. 35, N 11. С. 3011 - 3018.

840. Mosenthal W.P. и др. Thromboprophylaxis in Spinal Surgery.//Spine (Phila. Pa. 1976). Wolters Kluwer, 2018. Т. 43, N 8. С. E474 - E481.

841. Shiqing W. и др. Efficacy of low molecular weight heparin in spinal trauma patients after part concentrated screw surgery and its influence on blood parameters and the incidence of deep venous thrombosis.//Med. Hypotheses. Elsevier, 2019. Т. 132. С. 109330.

842. Faraoni D. и др. European guidelines on perioperative venous thromboembolism prophylaxis: Neurosurgery.//Eur. J. Anaesthesiol. Lippincott Williams and Wilkins, 2018. Т. 35, N 2. С. 90 - 95.

843. Routhier N., Tagalakis V., Bouchard-Duchene V. Venous thromboembolism (VTE) prophylaxis - Symptoms, diagnosis and treatment | BMJ Best Practice US. 2017.

844. Хороненко В.Э., Чиссов В.И., Суворин П.А. Периоперационная профилактика венозных тромбоэмболических осложнений в плановой онкохирургии//Res. Pract. Med. J. Общество с ограниченной ответственностью "КВАЗАР", 2016. Т. 3, N 4.

845. Kim S.M. и др. Risk factors for post-operative venous thromboembolism in patients with a malignancy of the lower limb.//Bone Joint J. 2013. Т. 95-B, N 4. С. 558 - 562.

846. Morii T., Mochizuki K., Tajima T. Venous thromboembolism in the management of patients with musculoskeletal tumor//J. Orthop. Sci. Springer Tokyo, 2010. Т. 15, N 6. С. 810 - 815.

847. Nathan S.S. и др. Proximal deep vein thrombosis after hip replacement for oncologic indications.//J. Bone Joint Surg. Am. LWW, 2006. Т. 88, N 5. С. 1066 - 1070.

848. Ruggieri P. и др. Clinically significant thromboembolic disease in orthopedic oncology: An analysis of 986 patients treated with low-molecular-weight heparin//J. Surg. Oncol. Wiley Online Library, 2010. Т. 102, N 5. С. 375 - 379.

849. Patel A.R. и др. Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients.//J. Surg. Oncol. Wiley Online Library, 2010. Т. 102, N 3. С. 276 - 281.

850. Singh V.A., Yong L.M., Vijayananthan A. Is DVT prophylaxis necessary after oncology lower limb surgery? A pilot study.//Springerplus. SpringerOpen, 2016. Т. 5, N 1. С. 943.

851. Carrier M. и др. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?//Ann. Intern. Med. American College of Physicians, 2008. Т. 149, N 5. С. 323 - 333.

852. Watson H.G., Keeling D.M., Laffan M. Guideline on aspects of cancer-related venous thrombosis//Br. J. Haematol. 2015. Т. 170, N 5. С. 640 - 648.

853. Kaiser C.L. и др. Predictors of venous thromboembolism in patients with primary sarcoma of bone.//Surg. Oncol. Elsevier, 2017. Т. 26, N 4. С. 506 - 510.

854. Mitchell S.Y. и др. Venous thromboembolism in patients with primary bone or soft-tissue sarcomas.//J. Bone Joint Surg. Am. LWW, 2007. Т. 89, N 11. С. 2433 - 2439.

855. Ramo B.A. и др. Incidence of symptomatic venous thromboembolism in oncologic patients undergoing lower-extremity endoprosthetic arthroplasty.//J. Bone Joint Surg. Am. LWW, 2011. Т. 93, N 9. С. 847 - 854.

856. Yamaguchi T. и др. Deep-vein thrombosis after resection of musculoskeletal tumours of the lower limb//Bone Joint J. 2013. Т. 95-B, N 9. С. 1280 - 1284.

857. Cardiovascular Disease Educational and Research Trust и др. Prevention and treatment of venous thromboembolism: international consensus statement (guidelines according to scientific evidence).//Clin. Appl. Thromb. Hemost. SAGE Publications Sage CA: Los Angeles, CA, 2013. Т. 19, N 2. С. 116 - 118.

858. Gould M.K. и др. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.//Chest. Elsevier, 2012. Т. 141, N 2 Suppl. С. e227S - e277S.

859. Takvorian K. Should Combined Hormonal Contraception Be Stopped in the Perioperative Period?//NEJM Evid. Massachusetts Medical Society, 2022. Т. 1, N 1. С. EVIDtt2100050.

860. Nicolaides A.N. Prevention of deep vein thrombosis.//Geriatrics. 1973. Т. 28, N 2. С. 69 - 77.

861. Amin A.N., Girard F., Samama M.M. Does ambulation modify venous thromboembolism risk in acutely ill medical patients?//Thromb. Haemost. Schattauer GmbH, 2010. Т. 104, N 5. С. 955 - 961.

862. Machin M. и др. Systematic review on the benefit of graduated compression stockings in the prevention of venous thromboembolism in low-risk surgical patients.//Phlebology. SAGE Publications Sage UK: London, England, 2021. Т. 36, N 3. С. 184 - 193.

863. Shalhoub J. и др. Graduated compression stockings as adjuvant to pharmaco-thromboprophylaxis in elective surgical patients (GAPS study): randomised controlled trial.//BMJ. British Medical Journal Publishing Group, 2020. Т. 369. С. m1309.

864. Collins R. и др. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.//N. Engl. J. Med. 1988. Т. 318, N 18. С. 1162 - 1173.

865. Wille-J rgensen P. и др. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2003. N 4. С. CD001217.

866. Kakkos S. и др. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism//Cochrane Database Syst. Rev. John Wiley & Sons, Ltd, 2022. Т. 2022, N 1. С. CD005258.

867. Hajibandeh S. и др. Neuromuscular electrical stimulation for the prevention of venous thromboembolism.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2017. Т. 11, N 11. С. CD011764.

868. Lobastov K. и др. Electrical calf muscle stimulation with Veinoplus device in postoperative venous thromboembolism prevention.//Int. Angiol. 2014. Т. 33, N 1. С. 42 - 49.

869. Lobastov K. и др. Intermittent Pneumatic Compression in Addition to Standard Prophylaxis of Postoperative Venous Thromboembolism in Extremely High-risk Patients (IPC SUPER): A Randomized Controlled Trial.//Ann. Surg. LWW, 2021. Т. 274, N 1. С. 63 - 69.

870. Баринов В.Е., Лобастов К.В., Бояринцев В.В. Повышенные дозы гепарина в профилактике послеоперационных венозных тромбоэмболий у пациентов с высоким риском их развития: эффективность и безопасность//Современные проблемы науки и образования. Общество с ограниченной ответственностью" Издательский Дом" Академия..., 2013. N 6. С. 579.

871. Wall V. и др. Anti-Factor Xa measurements in acute care surgery patients to examine enoxaparin dose.//Am. J. Surg. Elsevier, 2018. Т. 216, N 2. С. 222 - 229.

872. Pannucci C.J. и др. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.//JAMA Surg. American Medical Association, 2019. Т. 154, N 8. С. 697 - 704.

873. Pannucci C.J. и др. Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical Procedure.//Ann. Thorac. Surg. Elsevier, 2018. Т. 106, N 2. С. 404 - 411.

874. Pannucci C.J. и др. Inadequate Enoxaparin Dosing Predicts 90-Day Venous Thromboembolism Risk among Plastic Surgery Inpatients: An Examination of Enoxaparin Pharmacodynamics.//Plast. Reconstr. Surg. LWW, 2017. Т. 139, N 4. С. 1009 - 1020.

875. Khoursheed M. и др. Therapeutic effect of low-molecular weight heparin and incidence of lower limb deep venous thrombosis and pulmonary embolism after laparoscopic bariatric surgery.//Surg. Laparosc. Endosc. Percutan. Tech. LWW, 2013. Т. 23, N 6. С. 491 - 493.

876. Rowan B.O. и др. Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.//Obes. Surg. Springer, 2008. Т. 18, N 2. С. 162 - 166.

877. Faraklas I. и др. Evaluation of an enoxaparin dosing calculator using burn size and weight.//J. Burn Care Res. Oxford University Press, 2013. Т. 34, N 6. С. 621 - 627.

878. Pannucci C.J. и др. Optimal Dosing of Prophylactic Enoxaparin after Surgical Procedures: Results of the Double-Blind, Randomized, Controlled FIxed or Variable Enoxaparin (FIVE) Trial.//Plast. Reconstr. Surg. LWW, 2021. Т. 147, N 4. С. 947 - 958.

879. Pannucci C.J., Rondina M.T. Should we be following anti-factor Xa levels in patients receiving prophylactic enoxaparin perioperatively?//Surgery. Elsevier, 2017. Т. 161, N 2. С. 329 - 331.

880. Fareed J. и др. Pharmacodynamic and pharmacokinetic properties of enoxaparin: implications for clinical practice.//Clin. Pharmacokinet. Springer, 2003. Т. 42, N 12. С. 1043 - 1057.

881. Feng J.-P. и др. Efficacy of intermittent pneumatic compression for venous thromboembolism prophylaxis in patients undergoing gynecologic surgery: A systematic review and meta-analysis.//Oncotarget. Impact Journals, LLC, 2017. Т. 8, N 12. С. 20371 - 20379.

882. Morris R.J., Woodcock J.P. Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis? A systematic review of direct clinical comparisons.//Ann. Surg. LWW, 2010. Т. 251, N 3. С. 393 - 396.

883. Rahn D.D. и др. Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review.//Obstet. Gynecol. LWW, 2011. Т. 118, N 5. С. 1111 - 1125.

884. O'Connell S. и др. The Use of Intermittent Pneumatic Compression in Orthopedic and Neurosurgical Postoperative Patients: A Systematic Review and Meta-analysis.//Ann. Surg. Wolters Kluwer, 2016. Т. 263, N 5. С. 888 - 889.

885. Zareba P. и др. Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery.//Br. J. Surg. Oxford University Press, 2014. Т. 101, N 9. С. 1053 - 1062.

886. Pavon J.M. и др. Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-Risk Surgical Patients: A Systematic Review.//J. Arthroplasty. Elsevier, 2016. Т. 31, N 2. С. 524 - 532.

887. Sobieraj D.M., Coleman C.I., Tongbram V. Comparative effectiveness of combined pharmacologic and mechanical thromboprophylaxis versus either method alone in major orthopedic surgery: a systematic review and meta analysis//Pharmacother. J. Hum. Pharmacol. Drug Ther. Wiley Online Library, 2013. Т. 33, N 3. С. 275 - 283.

888. Haut E.R. и др. The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis.//JAMA Surg. American Medical Association, 2014. Т. 149, N 2. С. 194 - 202.

889. Kaw R. и др. Inferior vena cava filters and postoperative outcomes in patients undergoing bariatric surgery: a meta-analysis.//Surg. Obes. Relat. Dis. Elsevier, 2014. Т. 10, N 4. С. 725 - 733.

890. Hull R.D. и др. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.//Ann. Intern. Med. American College of Physicians, 2001. Т. 135, N 10. С. 858 - 869.

891. Eikelboom J.W., Quinlan D.J., Douketis J.D. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.//Lancet (London, England). Elsevier, 2001. Т. 358, N 9275. С. 9 - 15.

892. Huo M.H., Muntz J. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.//Clin. Ther. Elsevier, 2009. Т. 31, N 6. С. 1129 - 1141.

893. Lu X., Lin J. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.//BMC Musculoskelet. Disord. Springer, 2018. Т. 19, N 1. С. 322.

894. Milinis K. и др. The effectiveness of graduated compression stockings for prevention of venous thromboembolism in orthopedic and abdominal surgery patients requiring extended pharmacologic thromboprophylaxis.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2018. Т. 6, N 6. С. 766 - 777. e2.

895. Ockelford P.A., Patterson J., Johns A.S. A double-blind randomized placebo controlled trial of thromboprophylaxis in major elective general surgery using once daily injections of a low molecular weight heparin fragment (Fragmin).//Thromb. Haemost. Schattauer GmbH, 1989. Т. 62, N 4. С. 1046 - 1049.

896. Pezzuoli G. и др. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group.//Int. Surg. 1989. Т. 74, N 4. С. 205 - 210.

897. Bergqvist D. и др. Thromboprophylaxis with a low molecular weight heparin (tinzaparin) in emergency abdominal surgery. A double-blind multicenter trial.//Vasa. 1996. Т. 25, N 2. С. 156 - 160.

898. Barbui T., Cassinelli G., Cortelazzo S. Comparison of low molecular weight heparin CY 216 and unfractionated heparin in preventing post-operative venous thromboembolism in general surgery: a preliminary results of a cooperative study//Fibrinolysis. Churchill Livingstone, 1990. Т. 4. С. 79.

899. Ceccato D. и др. Weight-adjusted versus fixed dose heparin thromboprophylaxis in hospitalized obese patients: A systematic review and meta-analysis.//Eur. J. Intern. Med. Elsevier, 2021. Т. 88. С. 73 - 80.

900. Хитарьян А.Г. и др. Новый подход к эффективной профилактике венозных тромбоэмболических осложнений в бариатрической хирургии: опыт одного центра.//Флебология. 2020. Т. 14, N 4.

901. Nutescu E.A. и др. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.//Ann. Pharmacother. SAGE Publications Sage CA: Los Angeles, CA, 2009. Т. 43, N 6. С. 1064 - 1083.

902. Rondina M.T. и др. Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients//Thromb. Res. Elsevier, 2010. Т. 125, N 3. С. 220 - 223.

903. Parikh S. и др. Adjusted-dose enoxaparin for VTE prevention in the morbidly obese//J. Pharm. Technol. SAGE Publications Sage CA: Los Angeles, CA, 2015. Т. 31, N 6. С. 282 - 288.

904. Kolluri R. и др. A randomized study of the safety and efficacy of fondaparinux versus placebo in the prevention of venous thromboembolism after coronary artery bypass graft surgery.//Am. Heart J. Elsevier, 2016. Т. 171, N 1. С. 1 - 6.

905. Spebar M.J. и др. Perioperative heparin prophylaxis of deep venous thrombosis in patients with peripheral vascular disease.//Am. J. Surg. Elsevier, 1981. Т. 142, N 6. С. 649 - 650.

906. Murakami M. и др. External pneumatic compression does not increase urokinase plasminogen activator after abdominal surgery.//J. Vasc. Surg. Elsevier, 2002. Т. 36, N 5. С. 917 - 921.

907. Toth S. и др. A meta-analysis and systematic review of venous thromboembolism prophylaxis in patients undergoing vascular surgery procedures.//J. Vasc. surgery. Venous Lymphat. Disord. Elsevier, 2020. Т. 8, N 5. С. 869 - 881. e2.

908. Ho K.M., Bham E., Pavey W. Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis.//J. Am. Heart Assoc. Am Heart Assoc, 2015. Т. 4, N 10. С. e002652.

909. Baca I. и др. [Prevention of thromboembolism in minimal invasive interventions and brief inpatient treatment. Results of a multicenter, prospective, randomized, controlled study with a low molecular weight heparin].//Chirurg. 1997. Т. 68, N 12. С. 1275 - 1280.

910. Borstad E. и др. Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery. II: Reduced dose of low molecular weight heparin.//Acta Obstet. Gynecol. Scand. Wiley Online Library, 1992. Т. 71, N 6. С. 471 - 475.

911. Boncinelli S. и др. Haemostatic molecular markers in patients undergoing radical retropubic prostatectomy for prostate cancer and submitted to prophylaxis with unfractioned or low molecular weight heparin.//Minerva Anestesiol. 2001. Т. 67, N 10. С. 693 - 703.

912. Bounameaux H. и др. Antithrombotic prophylaxis in patients undergoing laparoscopic cholecystectomy.//Thromb. Res. 1997. Т. 86, N 3. С. 271 - 273.

913. Pannucci C.J. и др. Benefits and Risks of Prophylaxis for Deep Venous Thrombosis and Pulmonary Embolus in Plastic Surgery: A Systematic Review and Meta-Analysis of Controlled Trials and Consensus Conference.//Plast. Reconstr. Surg. LWW, 2016. Т. 137, N 2. С. 709 - 730.

914. Sch nemann H.J. и др. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.//Blood Adv. American Society of Hematology Washington, DC, 2018. Т. 2, N 22. С. 3198 - 3225.

915. CLOTS Trials Collaboration и др. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial.//Lancet (London, England). Elsevier, 2009. Т. 373, N 9679. С. 1958 - 1965.

916. Muir K.W. и др. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke.//QJM. Oxford University Press, 2000. Т. 93, N 6. С. 359 - 364.

917. CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration и др. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial//Lancet. Elsevier, 2013. Т. 382, N 9891. С. 516 - 524.

918. CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial.//Lancet. Neurol. Elsevier, 2014. Т. 13, N 12. С. 1186 - 1192.

919. Spinelli M., Corea F., Bignamini V. Early vital and functional outcome of acute ischaemic stroke patients: influence of deep vein thrombosis prevention with pneumatic compression devices//J. Neurol. DR DIETRICH STEINKOPFF VERLAG PO BOX 10 04 62, D-64204 DARMSTADT, GERMANY, 2006. Т. 253. С. 135.

920. Group I.S.T.C. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.//Lancet (London, England). Elsevier, 1997. Т. 349, N 9065. С. 1569 - 1581.

921. Kay R. и др. Low-molecular-weight heparin for the treatment of acute ischemic stroke.//N. Engl. J. Med. Mass Medical Soc, 1995. Т. 333, N 24. С. 1588 - 1593.

922. Elias A. и др. [Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients)].//La Rev. Med. interne. 1990. Т. 11, N 1. С. 95 - 98.

923. Kwiecinski H., Pniewski J., Kaminska A. A randomized trial of fraxiparine in acute ischemic stroke//Cerebrovasc Dis. 1995. Т. 5. С. 234.

924. Hommel M. Fraxiparine in Ischaemic Stroke Study. FISS bis investigators group//Cerebrovasc Dis. 1998. Т. 8, N suppl 4. С. S19.

925. Chaudhry H., Yadav K., Dubey S. Low molecular weight heparin in acute ischemic stroke//Antiseptic. 2002. Т. 99. С. 31 - 32.

926. McCarthy S.T. и др. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke.//Lancet (London, England). Elsevier, 1977. Т. 2, N 8042. С. 800 - 801.

927. McCarthy S.T., Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke.//Age Ageing. Oxford University Press, 1986. Т. 15, N 2. С. 84 - 88.

928. Duke R.J., Turpie A.G.G., Bloch R.F. Cerebrovascular disease. 1983.

929. Orken D.N. и др. Prevention of Deep Venous Thrombosis and Pulmonary Embolism in Patients With Acute Intracerebral Hemorrhage//Neurologist. LWW, 2009. Т. 15, N 6. С. 329 - 331.

930. Zubkov A.Y., Wijdicks E.F.M. Deep venous thrombosis prophylaxis in cerebral hemorrhage//Rev. Neurol. Dis. 2009. Т. 6, N 1. С. 21 - 25.

931. Sherman D.G. и др. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.//Lancet (London, England). Elsevier, 2007. Т. 369, N 9570. С. 1347 - 1355.

932. Turpie A.G. и др. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.//Ann. Intern. Med. American College of Physicians, 1992. Т. 117, N 5. С. 353 - 357.

933. Dumas R. и др. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke.//Age Ageing. Oxford University Press, 1994. Т. 23, N 6. С. 512 - 516.

934. Diener H.-C. и др. Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial.//Stroke. Am Heart Assoc, 2006. Т. 37, N 1. С. 139 - 144.

935. Ageno W. и др. Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis.//J. Thromb. Thrombolysis. Springer, 2016. Т. 42, N 1. С. 90 - 98.

936. Alikhan R., Forster R., Cohen A.T. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)//Cochrane Database Syst. Rev. John Wiley & Sons, Ltd, 2014. Т. 2018, N 2. С. CD003747.

937. Dentali F. и др. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.//Ann. Intern. Med. American College of Physicians, 2007. Т. 146, N 4. С. 278 - 288.

938. Bump G.M. и др. How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials.//J. Hosp. Med. Wiley Online Library, 2009. Т. 4, N 5. С. 289 - 297.

939. Andr C., de Freitas G.R., Fukujima M.M. Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles//Eur. J. Neurol. Wiley Online Library, 2007. Т. 14, N 1. С. 21 - 32.

940. Fernando S.M. и др. VTE Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis.//Chest. Elsevier, 2022. Т. 161, N 2. С. 418 - 428.

941. Sandercock P.A.G., Counsell C., Kane E.J. Anticoagulants for acute ischaemic stroke.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2015. Т. 2015, N 3. С. CD000024.

942. Sj lander A. и др. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.//J. Intern. Med. Wiley Online Library, 2008. Т. 263, N 1. С. 52 - 60.

943. Sandercock P.A., Leong T.S. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2017. Т. 4, N 4. С. CD000119.

944. Wein L. и др. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.//Arch. Intern. Med. American Medical Association, 2007. Т. 167, N 14. С. 1476 - 1486.

945. Lloyd N.S. и др. Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis.//J. Thromb. Haemost. Wiley Online Library, 2008. Т. 6, N 3. С. 405 - 414.

946. Kanaan A.O. и др. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.//Clin. Ther. Elsevier, 2007. Т. 29, N 11. С. 2395 - 2405.

947. Kamphuisen P.W., Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?//Thromb. Res. Elsevier, 2007. Т. 119, N 3. С. 265 - 274.

948. Eikelboom J.W. Effect of fondaparinux 2.5 mg once daily on mortality: a meta-analysis of phase III randomized trials of venous thromboembolism prevention//Eur. Hear. J. Suppl. Oxford University Press, 2008. Т. 10, N suppl_C. С. C8 - C13.

949. Zhang C. и др. [The efficacy of intermittent pneumatic compression in the prevention of venous thromboembolism in medical critically ill patients].//Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011. Т. 23, N 9. С. 563 - 565.

950. Smyth R.M.D., Aflaifel N., Bamigboye A.A. Interventions for varicose veins and leg oedema in pregnancy.//Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2015. Т. 2015, N 10. С. CD001066.